Education
Postdoctoral Training
Research Training
Board Certification
Academic Appointments
Hospital Appointments
Committees
Societies and Memberships
Editorial Boards
Bibliography
Abstracts
Invited Presentations/Session Chairs - National and International
University of Manitoba,
College of Liberal Arts, 1966-1968
University of Manitoba,
College of Medicine, 1968-1972,
M.D., B. Sc.(Med)
POSTDOCTORAL TRAINING:
Surgery Internship, University of Minnesota
Hospitals, Minneapolis, MN., 1972-1973
Resident in Surgery, University of Minnesota
Hospitals, 1973-1979
Fellowship in Transplantation,
University of Minnesota Hospitals, 1979-1980
RESEARCH TRAINING:
Neonatology, University of Manitoba Medical
College, 1969-1970
Thesis: "The Effect of Inhibition of Fetal
Adrenal Corticosteroid Formation by
Metapyrone (SU 4885) on the Formation of
Surfactant in the Fetal Lung."
Transplantation and Immunology, University of
Minnesota Medical School, 1974-1977. Areas:
Islet and hepatocellular transplantation.
Clinical transplantation.
Top of page
BOARD CERTIFICATION:
American Board of Surgery, 1980
Recertified, 1989
Assistant Professor of Surgery,
State University of New York,
Downstate Medical Center,
Brooklyn, New York, 1980-1981
Assistant Professor of Surgery,
Albert Einstein College of Medicine,
Bronx, New York, 1981 to June 1986
Associate Professor of Surgery
Jack D. Weiler Hospital of the Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, 1986 - 1988
Associate Professor of Surgery
Director, Renal Transplant Service
University of Minnesota
Minneapolis, Minnesota 1988 - 1991
Professor of Surgery
Director, Renal Transplant Service
University of Minnesota
Minneapolis, Minnesota 1991
Attending in Surgery, Kings County Hospital,
Brooklyn, New York, 1980-1981.
Attending in Surgery, Montefiore Medical Center, Bronx, New York, 1981 - 1988
Attending in Surgery, University of Minnesota
Hospital and Clinic, 1988 - to date
Consultant, Minnesota Veterans Administration
Hospital, 1988 - to date
Compliance Officer, Surgery Clinical Services Unit, University of Minnesota Physicians, Inc., 1998 - to date
COMMITTEES:
Senate of Albert Einstein College of Medicine, 1982
Ambulatory Medical Audit Committee 1982 - 1985
Joint Med/Nursing Review Committee (HAECOM), 1983 - 1985
Resident Evaluation Committee (Surgery) (HAECOM) 1983 - 1988
Montefiore Medical Center Bioethics Committee 1984 - 1986
Director, Student Clerkships. Montefiore Medical Center 1984 - 1988
Quality Assurance Committee, University of Minnesota, 1988 - 1989
Pharmacy and Therapeutics Committee, University of Minnesota, 1988 -
Committee on Surgical Education, Society of University Surgeons, 1989 - 1992
Ethics Committee, American Society of Transplant Surgeons, 1990 - 1993
Publications Committee, American Society of Transplant Surgeons, 1991 - 94
Board of Directors, Upper Midwest Organ Procurement Organization 1988 -
Treasurer, Upper Midwest Organ Procurement Organization 1990 - 1992
President, Upper Midwest Organ Procurement Organization, 1996 -
Promotions & Tenure Committee, University of Minnesota, 1995 -
Scientific Study Committee, North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), 1996-1998
Committee on Organ Donation, American Society of Transplant Physicians, 1996-1999
Co-chair, ASTS/ASTP Scientific Studies Joint Subcommittee on Steroid Withdrawal in Clinical Transplantation
Standards in Organ Procurement Committee, ASTS 1996-1998
Membership Committee, ASTS, 1997-1999
Compliance Committee, University of Minnesota Physicians, 1998-
American Society of Transplant Physicians Awards Committee 1998-2001
Councilor, The International Society for Organ Sharing, 1999-
Nominations Committee, ASTS, 2000-2002
Informatics and Data Management Committee, ASTS, 2000-2001
Top of page
American College of Surgeons
American Society for Histocompatibility and Immunogenetics
American Society of Transplant Physicians
American Society of Transplant Surgeons
Association for Academic Surgery
International Society of Transplantation
Society of University Surgeons
The American Society of Nephrology
American Surgical Association
Top of page
EDITORIAL BOARDS:
Clinical Transplantation
Transplantation Science
Transplantation
Frontiers in Bioscience
Pediatric Transplantation
Nephrology News and Issues
Graft
Transplantation and Immunology Letter
1. *Matas AJ and Kremen AJ: Idiopathic systemic fibrosis - The simultaneous occurrence of retroperitoneal fibrosis and desmoid tumor. Minn Med 57: 279-280, 1974.
2. *Matas AJ, Simmons RL, Buselmeier TJ, Najarian JS, and Kjellstrand CM: Lethal complications of bilateral nephrectomy and splenectomy in hemodialyzed patients. Am J Surg 129: 616-620, 1975.
3. *Matas AJ, Simmons RL, Kjellstrand CM, Buselmeier TJ, and Najarian JS: Increased incidence of malignancy during chronic renal failure. Lancet 1: 883-886, 1975.
4. *Matas AJ, Simmons RL, and Najarian JS: Hypothesis - Chronic antigenic stimulation, viral-activation and malignancy in the transplant recipient. Lancet 1: 1277-1279, 1975.
5. *Matas AJ, Simmons RJ, Kersey JH, Kjellstrand CM, and Najarian JS: Cytomegalovirus and lymphoma in a pediatric transplant recipient. J Pediatr 87: 494-495, 1975.
6. Matas AJ, Sutherland DER, Steffes MW, Simmons RL, and Najarian JS: Hepatocellular transplantation in UDP-glucuronyl transferase deficient rats. Surg Forum 26: 428-430, 1975.
7. *Matas AJ, Simmons RL, Kjellstrand CM, and Najarian JS.: Increased serum creatinine resulting from hyperglycemia mimicking rejection. Ann Intern Med 83: 519, 1975.
8. *Matas AJ, Simmons RL, Buselmeier TJ, Kjellstrand CM, and Najarian JS: Successful transplantation in patients with prior history of malignancy. Am J Med 59: 791-795, 1975.
9. *Buselmeier TJ, Simmons RL, Duncan DA, Toledo LH, Mauer SM, Matas AJ, Hong C, Najarian JS, and Kjellstrand CM: Local steroid treatment of intractable ascites in dialysis patients. Proc Clin Dialysis Transpl Forum 5: 9-11, 1975.
10. *Matas AJ, Simmons RL, Goetz FC, Kjellstrand CM, Buselmeier TJ, and Najarian JS: Hyperglycemic pseudorejection in the diabetic transplant recipient. Surgery 79: 132-137, 1976.
11. Burk M, Matas AJ, and Simmons RL: Paraneoplastic syndromes. In: Najarian JS, and Delaney JP (eds): Advances in Cancer Surgery, Miami: Symposia Specialists, 1976, pp. 145-151.
12. Najarian JS and Matas AJ: Cancer in the immunosuppressed patient. In: Najarian JS and Delaney JP (eds): Advances in Cancer Surgery, Miami: Symposia Specialists, 1976, pp. 129-133.
13. *Matas AJ, Simmons RL, Kjellstrand CM, Buselmeier TJ, and Najarian JS: Transplantation of the aging kidney. Transplantation 21: 160-161, 1976.
14. *Matas AJ, Mauer SM, Sutherland DER, Spanos P, Simmons RL, and Najarian JS: Polar infarct of a kidney transplant simulating appendicitis. Am J Surg 131: 363-365, 1976.
15. *Matas AJ, Sutherland DER, Steffes MW, and Najarian JS: Islet transplantation using neonatal pancreata: Quantitative studies. J Surg Res 20: 143-147, 1976.
16. *Buselmeier TJ, Simmons RL, Najarian JS, Mauer SM, Matas AJ, and Kjellstrand CM.: Uremic pericardial effusion: Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron 16: 371-380, 1976.
17. *Matas AJ, Sutherland DER, Steffes MW, Mauer SM, Simmons R, and Najarian JS: Hepatocellular transplantation for metabolic diseases: Decreased serum bilirubin in uridine diphosphate glucuronyl transferase (UDPGT) deficient rats. Science 192: 892-894, 1976.
18. *Matas AJ, Sutherland DER, Steffes MW, and Najarian JS: Minimal collagenase digestion: Amelioration of diabetes with transplantation of one dispersed neonatal pancreas. Transplantation 22: 71-73, 1976.
19. *Matas AJ, Sutherland DER, Steffes MW, and Najarian JS: Short term culture of adult pancreatic fragments for purification and transplantation of islets of Langerhans. Surgery 80: 183-191, 1976.
20. *Matas AJ, Sutherland DER, and Najarian JS: The current status of islet and pancreas transplantation. Diabetes 25: 785-795, 1976.
21. *Matas AJ, Simmons RL, Kjellstrand CM, Buselmeier TJ, and Najarian JS: Fate of renal transplant recipient surviving three years posttransplantation. Surgery 80: 390-395, 1976.
22. *Matas AJ, Sutherland DER, Steffes MW, and Najarian JS: Islet transplantation following prolonged warm ischemia of rat neonatal donors. Surg Forum 27: 343-345, 1976.
23. *Najarian JS, Simmons RL, Condie RM, Thompson EJ, Fryd DS, Howard RJ, Matas AJ, Sutherland DER, Ferguson RM, and Schmidtke JR: Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg 184: 352-368, 1976.
24. *Matas AJ, Hertel B, Rosai J, Simmons RL, and Najarian JS: Post-transplant malignant lymphoma - distinctive morphologic features related to its pathogenesis. Am J Med 61: 716-721, 1976.
25. *Matas AJ, Sheinman J, Rattazzi L, Mozes M, Simmons RL, and Najarian JS: Immunopathologic studies of the ruptured human renal allograft. Transplantation 5: 420-426, 1976.
26. *Sutherland DER, Kjellstrand CM, Simmons RL, Mauer SM, Buselmeier TJ, Goetz FC, Matas AJ, Haymond M, Howard RJ, Buls J, and Najarian JS: Renal transplantation in the diabetic. Minn Med 59: 766-771, 1976.
27. *Sutherland DER, Matas AJ, Steffes MW, and Najarian JS: Infant human pancreas: A potential source of islet tissue for transplantation. Diabetes 25: 1123-1128, 1976.
28. Kjellstrand CM, Davin TJ, Matas AJ, and Buselmeier TJ: Postoperative acute renal failure: Diagnosis, etiologic and symptomatic treatment and prognosis. In: Najarian JS and Delaney JP (eds): Critical Surgical Care, New York: Stratton International Medical Book Corp, 1977, pp. 309-334.
29. *Matas AJ, Payne WD, Simmons RL, Buselmeier TJ, and Kjellstrand CM.: Acute renal failure following blunt civilian trauma. Ann Surg 185: 301-306, 1977.
30. Matas AJ, Najarian JS, and Simmons RL: The complex pathogenesis of cancer in the transplant recipient. Compr Ther 3: 49-53, 1977.
31. *Matas AJ, Simmons RL, Kjellstrand CM, and Najarian JS: Pseudorejection: Factors mimicking rejection in renal allograft recipients. Ann Surg 186: 51-59, 1977.
32. *Sutherland DER, Matas AJ, and Najarian JS: Pancreas and islet transplantation for diabetes mellitus. World J Surg 1: 185-195, 1977.
33. Matas AJ, Sutherland DER, Kretschmer G, Steffes MW, and Najarian JS: Pancreatic tissue culture: Depletion of exocrine enzymes and purification of islets for transplantation. Transplant Proc 9: 337-339, 1977.
34. Najarian JS, Sutherland DER, Matas AJ, Steffes MW, and Goetz FC: Human islet transplantation: A preliminary experience. Transplant Proc 9: 233-236, 1977.
35. Sutherland DER, Matas AJ, Steffes MW, Simmons RL, and Najarian JS: Transplantation of liver cells in an animal model of congenital enzyme deficiency disease: The Gunn rat. Transplant Proc 9: 317-320, 1977.
36. Matas AJ, Simmons RL, Kjellstrand CM, Buselmeier TJ, and Najarian JS: Increased incidence of malignancy in uremic patients. Transplant Proc 9: 1977.
37. *Matas AJ, Sutherland DER, Payne WD, Kretschmer GJ, Steffes MW, and Najarian JS: Islet transplantation: The critical period of donor ischemia in neonatal rats. Transplantation 23: 295-298, 1977.
38. *Matas AJ, Simmons RL, Kjellstrand CM, Fryd DS, and Najarian JS: When should the third renal transplant rejection episode be treated? Ann Surg 186: 114-120, 1977.
39. *Simmons RL, Matas AJ, Rattazzi LC, Balfour HH, Howard RJ, and Najarian JS: Clinical characteristics of the lethal cytomegalovirus syndrome. Surgery 82: 537-546, 1977.
40. *Sutherland DER, Numata M, Matas AJ, Simmons RL, and Najarian JS: Hepatocellular transplantation in acute liver failure. Surgery 82: 124-132, 1977.
41. *Kretschmer GJ, Sutherland DER, Matas AJ, Cain TL and Najarian JS: Autotransplantation of pancreatic islets without separation of exo and endocrine tissue in totally pancreatectomized dogs. Surgery 82: 74-81, 1977.
42. *Matas AJ, Sutherland DER, Steffes MW, and Najarian JS: Islet transplantation. Surg Gynecol Obstet 145: 757-772, 1977.
43. Payne WD, Sutherland DER, Matas AJ, and Najarian JS: Amelioration of diabetes in rats by transplantation of islet tissue from a single donor to multiple recipients. Surg Forum 28: 301-304, 1977.
44. Numata M, Sutherland DER, Matas AJ, Simmons RL, and Najarian JS: Allogenic liver cell transplantation for acute hepatic failure. Surg Forum 28: 307-309, 1977.
45. Kretschmer GJ, Sutherland DER, Matas AJ, Olson L, and Najarian JS: Islet autotransplantation in pancreatectomized dog: Liver vs. spleen as a site of pancreatic tissue implantation. Surg Forum 28: 292-294, 1977.
46. *Kretschmer GJ, Sutherland DER, Matas AJ, Steffes MW, and Najarian JS: The dispersed pancreas: Transplantation without islet purification in totally pancreatectomized dogs. Diabetologia 13: 495-502, 1977.
47. Matas AJ, Sutherland DER, Payne WD, Steffes MW, Kretschmer GJ, and Najarian JS: Successful transplantation of neonatal rat islet tissue preserved up to 63 hours. Trans Amer Soc Artif Int Organs 23: 347-350, 1977.
48. Sutherland DER, Kretschmer GJ, Matas AJ, and Najarian JS: Experience with transplantation of pancreatic fragments to the spleen of totally pancreatectomized dogs. Trans Amer Soc Artif Int Organs 23: 723-725, 1977.
49. *Matas AJ, Payne WD, Grotting JC, Sutherland DER, Steffes MW, Hertel B, and Najarian JS: Portal vs. systemic islet transplantation using neonatal donors. Transplantation 24: 333-337, 1977.
50. Matas AJ, Simmons RL, and Desnick RJ: Organ and tissue transplantation for the treatment of metabolic disease. In: Buchwald H and Varco RL (eds): Surgery in Metabolic Disease, New York: Grune and Stratton, 1978, pp. 177-227.
51. *Matas AJ, Sutherland DER, Payne WD, Ekhardt J, and Najarian JS: A mouse model of islet transplantation using neonatal donors. Transplantation 24: 389-393, 1978.
52. *Kretschmer GJ, Sutherland DER, Matas AJ, Payne WD, and Najarian JS: Autotransplantation of pancreatic fragments to the portal vein and spleen of totally pancreatectomized dogs: A comparative evaluation. Ann Surg 187: 79-86, 1978.
53. Matas AJ and Simmons RL: The role of viruses in the pathogenesis of cancer in renal transplant recipients. In: Transplantation and Clinical Immunology, Amsterdam-Oxford: Vol. IX (prox. 9th International Course, Lyon, June 6-8, 1977). Excerpta Medica, 1978, pp. 71-80.
54. Sutherland DER, Matas AJ, and Najarian JS: Pancreatic islet cell transplantation. In Symposium on Organ Transplantation. Surg Clin North Am 58: 365-382, 1978.
55. *Matas AJ, Payne WD, Sutherland DER, and Najarian JS: On the interpretation of islet allograft and xenograft data. Transplantation 25: 281-283, 1978.
56. *Sheinman JI, Fish AJ, Matas AJ, and Michael AF: The immunohistopathology of glomerular antigens. II. The glomerular basement membrane, actomyosin and fibroblast surface antigens in normal, diseased and transplanted human kidneys. Am J Pathol 90: 71-88, 1978.
57. *Matas AJ, Simmons RL, Desnick RJ, and Najarian JS: Clinical and experimental transplantation in enzymatic deficiency diseases. Surg Gynecol Obstet 146: 975-982, 1978.
58. *Vialettes B, Sutherland DER, Payne WD, Matas AJ, and Najarian JS: Synergistic effect of donor specific soluble membrane antigen injection and antilymphocyte globulin administration on the survival of islet allografts in rats. Transplantation 25: 336-338, 1978.
59. *Mauer SM, Brown DM, Matas AJ, and Steffes MW: Effects of pancreatic islet transplantation upon the increased urinary albumin excretion rates in intact and uni-nephrectomized rats with diabetes mellitus. Diabetes [YEAR?];27: 959-964.
60. *Grotting JC, Rosai J, Matas AJ, Payne WD, Sutherland DER, and Najarian JS: Morphological and immunohistochemical studies on intraportally transplanted islets in diabetic rats. Am J Pathol 92: 653-670, 1978.
61. Howard RJ, Sutherland DER, Matas AJ, and Najarian JS: Successful treatment of viral induced diabetes mellitus by islet transplantation. Surg Forum 29: 343-345, 1978.
62. Payne WD, Sutherland DER, Matas AJ, and Najarian JS: Cryopreservation of neonatal rat islet tissue. Surg Forum 29: 347-349, 1978.
63. Vialettes B, Matas AJ, Sutherland DER, Payne WD, and Najarian JS: Effect of islet transplantation on plasma lipid levels in diabetic rats. Surg Forum 29: 345-347, 1978.
64. Hong C, Sutherland DER, Matas AJ, Simmons RL, and Najarian JS: Enzyme replacement in acatalasemic mice by bone marrow transplantation. Surg Forum 29: 333-335, 1978.
65. Matas AJ, Sutherland DER, and Najarian JS: Transplantation of hepatocytes and pancreatic islets. In: Gregoriadis, G. (eds): Drug Carriers in Biology and Medicine, London: Academic Press, 1979, pp. 191-209.
66. *Payne WD, Sutherland DER, Matas AJ, Gorecki P, and Najarian JS: DL-enthionine treatment of adult pancreatic donors: Amelioration of diabetes in multiple recipients with tissue from a single donor. Ann Surg 189: 248-256, 1979.
67. *Vialettes B, Sutherland DER, Matas AJ, Payne WD, and Najarian JS: Amelioration of streptozotocin induced diabetes in rats: Effect of islet isografts on plasma lipids and other metabolic abnormalities according to donor source and site of transplantation. Metabolism 28: 489-494, 1979.
68. *Howard RJ, Balfour HH, Jr, Matas AJ, Najarian JS, and Sutherland, D.E.R.: Encephalomyocarditis virus-induced diabetes mellitus treated by islet transplantation. Transplantation 27: 200-202, 1979.
69. *Steffes MW, Brown DM, Basgen J, Matas AJ, and Mauer SM: Glomerular basement membrane thickness following islet transplantation in the rat. Lab Invest 41: 116-118, 1979.
70. *Lum CT, Sutherland DER, Eckhardt J, Matas AJ, and Najarian JS: Effect of an adenosine deaminase (ADA) inhibitor on survival of mouse pancreatic islet allografts. Transplantation 27: 355-357, 1979.
71. Kretschmer GJ, Sutherland DER, Matas AJ, and Najarian JS: Preliminary experience with allotransplantation of pancreatic fragments to the spleen of totally pancreatectomized dogs. Transplant Proc 11: 537-542, 1979.
72. Sommer BG, Sutherland DER, Matas AJ, and Najarian JS: Hepatocellular transplantation for treatment of D-galactosamine induced acute liver failure in rats. Transplant Proc 11: 578-584, 1979.
73. Najarian JS, Sutherland DER, Matas AJ, and Goetz FC: Human islet autotransplantation following pancreatectomy. Transplant Proc 11: 336-340, 1979.
74. Hong C, Sutherland DER, Matas AJ, and Najarian JS: Bone marrow transplantation for correction of enzyme deficiency disease. Transplant Proc 11: 498-503, 1979.
75. Howard RJ, Matas AJ, Balfour HH, Cohn R, Najarian JS, and Sutherland DER: Reversal of encephalomyocarditis virus-induced diabetes mellitus by islet transplantation. Transplant Proc 11: 557-559, 1979.
76. Foker JE, Schwartz R, Smith DC, and Matas AJ: Surgical problems arising in immunodeficient and immunosuppressed children. Surg Clin North Am 59: 213-221, 1979.
77. Sutherland DER, Matas AJ, Kretschmer GJ, and Najarian JS: Clinical applications and future of islet transplantation. In: Touraine JL et al. (eds): Transplantation and Clinical Immunology, Amsterdam-Oxford, Vol. 10. Excerpta Medica, 1979, pp. 227-231.
78. Sutherland DER, Frenzel E, Payne DW, Matas AJ, and Najarian JS: Transplantation of adult islet tissue in rats: Spleen vs. portal vein site. Surg Forum 30: 305-307, 1979.
79. *Lum CT, Sutherland DER, Matas AJ, Eckhardt J, and Najarian JS: Prolongation of mouse pancreatic islet cell allografts by inhibition of adenosine deaminase (ADA). J Surg Res 28: 44-48, 1980.
80. Matas AJ, Simmons RL, and Najarian JS: Sepsis following renal transplantation. In: Hardy JD (ed): Critical Surgical Illness, Philadelphia: W.B. Saunders Co, 1980, pp. 552-590.
81. *Sutherland DER, Matas AJ, Goetz FC, and Najarian JS: Transplantation of dispersed pancreatic islet tissue in humans: Autografts and allografts. Diabetes 29 (Suppl. 1): 31-44, 1980.
82. Sutherland DER, Goetz FC, Rynasiewicz J, Kawahara K, Matas AJ, Payne WD, Baumgartner D, and Najarian JS: Pancreas and islet transplantation for clinical and experimental diabetes. In: Bibergeil H, Zuhlke H, and Poser U (eds): Proc. of X. Karlsberg Symposium: Early Diabetes - Pathogenesis, Diagnosis, Prevention. Karlsberg: Cent. Inst. Diabetes Gerhardt Katsch, 1980, pp. 225-278.
83. Najarian JS, Sutherland DER, Matas AJ, and Goetz FC: Near total pancreatectomy with islet cell autotransplantation for chronic pancreatitis. In: Najarian JS and Delaney JP (eds): Hepatic, Biliary and Pancreatic Surgery. Year Book Medical Publishers, Chicago, 1980, pp. 357-371.
84. *Grotting JC, Rosai J, Matas AJ, Frenzel EM, Huchnert L, Sutherland DER, and Najarian JS: Morphologic characterization of long term pancreatic islet transplants in diabetic rats. Minn Med 63: 321-326, 1980.
85. *Sutherland DER, Matas AJ, and Najarian JS: The mutual impact of transplantation on advances in the understanding and treatment of metabolic diseases. Transplant Proc 12: 634-642, 1980.
86. Najarian JS, Sutherland DER, Baumgartner D, Burke B, Rynesiewicz J, Matas AJ, and Goetz FC: Total or near total pancreatectomy and islet autotransplantation for treatment of pancreatitis. Ann Surg 192: 526-542, 1980.
87. Kjellstrand C, Matas A, Cosio F, and Davin T: Are malignancies increased in uremia and dialysis? Proc 8th Int Cong Neph, Athens, pp. 1217-1222, 1981.
88. Matas AJ, Simmons RL, Fryd D, and Najarian JS: Persistent, recurrent and late cytomegalovirus infection. Transplant Proc 13: 114-116, 1981.
89. Matas AJ and Najarian JS: Defining who is at high risk for breast cancer. In: Najarian JS and Delaney JP (eds): Breast Surgery, New York: Appleton-Century-Crofts, 1981, pp. 1-14.
90. *Hong JH, Shirani K, Arshad A, Parsa I, Matas A, Adamsons R and Butt K: Influence of cadaver donor age on the success of kidney transplantation. Transplantation 32: 532-534, 1981.
91. *Matas AJ, Sutherland DER, Payne WD, Van Hook EJ, Simmons RL, and Najarian JS: Retrieval of kidneys for transplantation from cadaveric donors in Minnesota: One center's experience. Minn Med 65: 165-166, 1982.
92. *Matas AJ, Sibley R, Mauer SM, Kim T, Sutherland DER, Simmons RL, and Najarian JS: Pre-discharge, post-transplant kidney biopsy does not predict rejection. J Surg Res 32: 269-274, 1982.
93. *Norin AJ, Emeson EE, Kamholz SL, Pinsker KL, Montefusco CM, Matas AJ, and Veith FJ: Cyclosporine A as the initial immunosuppressive agent for canine lung transplantation: Short and long term assessment of rejection phenomena. Transplantation 34: 372-375, 1982.
94. *Matas AJ, Tellis VA and Veith FJ: Renal transplantation in the patient with juvenile onset diabetes mellitus - An overview. NY State J Med 82: 1015-1019, 1982.
95. Mollenkopf F, Matas A, Veith FJ, Sprayregen S, Soberman R, Kuemmel P, Tellis V, Sniderman K, Sos T, Cheigh JS, and Stubenbord W Jr.: Percutaneous transluminal angioplasty for transplant renal artery stenosis. Transplant Proc 15: 1089-1091, 1983.
96. *Matas AJ, Sibley RK, Mauer SM, Sutherland DER, Simmons RL, and Najarian JS: The value of needle renal allograft biopsy. I. A retrospective study of biopsies performed during putative rejection episodes. Ann Surg 197: 226-237, 1983.
97. *Sutherland DER, Morrow CE, Florak G, Kretschmer G, Bumgardner G, Matas AJ, and Najarian JS: Cold storage preservation of islet and pancreas grafts as assessed by in vitro function after transplantation to diabetic hosts. Cryobiology 20: 138-150, 1983.
98. Matas AJ, Miller JB, Schneider PD, Sutherland DER, Simmons RL, and Najarian JS: Assessment of 215 consecutive posttransplant hospital readmissions for renal allograft recipients at a single institution. Transplant Proc 15: 1702-1704, 1983.
99. *Matas AJ, Tellis VA, Veith FJ, Kuemmel P, Mollenkopf F, Karwa G, and Soberman R: The fate of the patient returned to hemodialysis after losing a renal transplant. JAMA 250: 1053-1056, 1983.
100. Matas AJ, Nehlsen-Cannarella SL, Tellis VA, Kuemmel P, Soberman RJ, and Veith FJ: Renal transplantation in patients having positive crossmatch with historical sera. Surg Forum 34: 415-416, 1983.
101. *Payne WD, Sutherland DER, Matas AJ, and Najarian JS: Successful long-term cryopreservation of neonatal rat islet tissue. Cryobiology 20: 226-229, 1983.
102. *Matas AJ, Nehlsen-Cannarella S, Tellis VA, Kuemmel P, Soberman R, and Veith FJ: Successful kidney transplantation with current sera negative/historical sera positive T cell crossmatch. Transplantation 37: 111-112, 1984.
103. *Kamholz S, Veith FJ, Mollenkopf F, Montefusco C, Nehlsen-Cannarella S, Kaleya R, Pinsker K, Tellis V, Soberman R, Sablay L, Matas A, Gliedman M, Goldsmith J, Fell S, Brodman R, Merav A, Shander A, Hollinger I, and Nagashima H: Single lung transplantation in paraquat intoxication. NY State J Med 84: 82-84, 1984.
104. *Dunn DL, Matas AJ, Fryd DS, Simmons RL, and Najarian JS: Association of concurrent herpes simplex virus and cytomegalovirus with detrimental effects after renal transplantation. Arch Surg 119: 812-817, 1984.
105. *Matas AJ, Sablay L, Tellis VA, Kuemmel P, Soberman R, Veith FJ: The value of renal allograft biopsy. II. Reflection of acute rejection changes throughout the kidney by percutaneous biopsy. Transplantation 38: 92-93, 1984.
106. *Matas AJ and Veith FJ: Presumed consent for organ donation. Theor Med 5: 155-166, 1984.
107. Matas AJ, Tellis V, Quinn T, Glicklich D, Soberman R, Veith F: Renal transplant rejection treatment - a cost effective approach. Transplant Proc 17: 189-190, 1985.
108. *Matas AJ: Death with dignity. A personal look into a major moral conflict for the physician in today's society. Minn Med 68: 209, 1985.
109. *Tellis VA, Matas AJ, Glicklich D, Quinn T, Soberman R, Weiss R, Veith FJ: Cyclosporine: preliminary experience in 79 renal transplants. NYS J Med 85: 531-534, 1985.
110. *Matas AJ, Arras J, Muyskens J, Tellis VA, Veith FJ: A proposal for cadaver organ procurement: Routine removal with right of informed refusal. J Health Politics, Policy and Law 10: 231-244, 1985.
111. *Matas AJ, Tellis VA, Sablay L, Quinn T, Soberman R, Veith FJ: The value of needle renal allograft biopsy III. A prospective study. Surgery 98: 922-926, 1985.
112. *Matas AJ, Tellis VA, Quinn T, Karwa G, Glicklich D, Soberman R and Veith FJ: Treatment of renal transplant rejection episodes in patients receiving prednisone and azathioprine - a cost effective approach. Transplantation 40: 35-39, 1985.
113. Tellis VA, and Matas AJ: Transplantation Surgery. In: Gold MS, Scher LA and Weinberg G (eds): General Surgery Board Review. New York: Raven Press, 1986, pp 138-151
114. *Wengerter K, Matas AJ, Tellis VA, Quinn T, Soberman R and Veith FJ: Transplantation of pediatric donor kidneys to adult recipients - is there a critical donor age? Ann Surg 204: 172-175, 1986.
115. *Matas AJ, Tellis VA, Gupta SK, Quinn T, Soverman R, Veith FJ: An integrated microcomputer system for transplant data retrieval and analysis. Dialysis and Transplantation 15: 309-311, 1986.
116. *Matas AJ, Tellis VA, Quinn T, Glicklich D, Soverman R, Weiss R, Veith FJ: ALG treatment of steroid resistant rejection in patients receiving cyclosporine. Transplantation 41: 579-582, 1986.
117. *Odenheimer D, Matas AJ, Tellis VA, Quinn T, Glicklich D, Soberman R, Veith FJ: Donor cultures reported positive following renal transplantation - a clinical dilemma. Transplant Proc 18: 465-466, 1986.
118. Wengerter K, Matas AJ, Tellis VA, Quinn T, Soberman R, Veith FJ: Which pediatric donor kidneys should be transplanted to adults? Transplant Proc 18: 475-476, 1986.
119. Matas AJ, Tellis VA, Quinn T, Soberman R, Veith FJ: Definition, Diagnosis and Management of Rejection in the Second to Sixth Months Posttransplant - An Overview. Transplant Proc 18: 11: 141-147, 1986.
120. *Gordon JV, White R, Matas AJ, Tellis VA, Glicklich D, Quinn T, Soberman R, Veith FJ: Renal transplantation in patients with a history of heroin abuse. Transplantation 42: 556-557, 1986.
121. Matas AJ and Veith FJ: Presumed consent - A more humane approach to cadaver organ donation. In: Kutscher AH (ed): Positive approaches to living with end stage renal disease: Psychosocial aspects for the patient family, staff, and community, 1987.
122. Matas AJ and Simmons RL: Sepsis following kidney transplantation. In: Santiago-Delpin E, Ruiz-Speare O and Chavez, Peon R (eds): Transplante De Organos, Salvat, 1987.
123. *Glicklich D, Matas AJ, Sablay LG, Senitzer D, Tellis VA, Soberman R, and Veith FJ: Recurrent membranoproliferative glomerulonephritis type 1 in successive renal transplants. Am J Nephrol 7: 143-149, 1987.
124. Neiberger RE, Weiss RA, Greiffer I, Tellis VA and Matas AJ: Elimination kinetics of cyclosporine following oral administration to children with renal transplants. Transplant Proc 19: 1525, 1987.
125. Tellis VA, Matas AJ, Quinn TA, Glicklich D, Weiss R, Soberman R and Veith FJ: Antilymphoblast globulin treatment of steroid resistant rejection in cyclosporine immunosuppressed renal transplant recipients. Transplant Proc 19: 1892, 1987.
126. *Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R and Veith FJ: Timing of cyclosporine administration in patients with posttransplant ATN. J Surg Res 43: 489-494, 1987.
127. *Matas AJ, Tellis VA, Karwa GL, Quinn TA, Hershman J, Soberman R, Bard R, Veith FJ: Comparison of posttransplant urologic complications following extravesical ureteroneocystostomy by a "single stitch" or "mucosal" anastomosis. Clin Transplantation 1: 159-163, 1987.
128. *Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R, Veith FJ: Does race affect renal transplant results? - a single institution study. Clin Transplantation 1: 261-264, 1987.
129. Tellis VA, Matas AJ and Veith FJ: Vascular complications in transplantation. In: Cerilli, G.J, Lippincott, J.B, (eds): Organ Transplantation and Replacement, 1988, pp 423-433
130. *Tellis VA, Weiss P, Matas A and Veith FJ: Skin-flap coverage of polytetrafluorethylene vascular access graft exposed by previous infection. Surgery 103: 118-121, 1988.
131. Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman RJ, Veith FJ: The effect of referring dialysis center on transplant outcome. Transplant Proc 20 (Suppl.1): 375-376, 1988.
132. Senitzer D, Matas AJ, Tellis VA, Veith FJ, Soberman R: Do shared HLA antigens between present and past donors adversely affect graft survival in recipients with a past positive donor crossmatch? Transplant Proc 20 (Suppl.1): 34-36, 1988.
133. *Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R, Veith FJ: Individualization of immediate posttransplant immunosuppression - the value of ALG in patients with delayed graft function. Transplantation 45: 406-409, 1988.
134. *Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman R, Veith FJ: Successful transplantation of highly sensitized patients without regard to HLA matching. Transplantation 45: 338-342, 1988.
135. Perez LM, Matas AJ, Tellis VA: Organ donation in three United States cities by race/ethnicity. Transplant Proc 20: 815, 1988.
136. *Matas AJ, Quinn TA, Tellis VA, Glicklich D, Soberman R, Veith FJ: Referring dialysis center affects renal transplant results. Transplantation 45: 894-898, 1988.
137. *Glicklich D, Seegmiller JE, Matas AJ, Tellis VA, Quinn TA, Karwa G, Kenner K, Finley K, Gruber HE, Soberman R, Veith FJ: 2,8-dihydroxyadenine urolithiasis: Report of a case first diagnosed following renal transplantation. Quart J Med 69: 785-793, 1988.
138. *Stein M, Matas AJ, Tellis VA, Quinn TA, Karwa GL, Glicklich D, Soberman RJ, Veith FJ: When is further ALG administration futile? Transplantation 46: 464-466, 1988.
139. *Perez LM, Matas AJ, Tellis VA, Schulman B, Davis F, Olson L: Organ donation in three major American cities with large latino and black populations. Transplantation 46: 553-557, 1988.
140. *Matas AJ, Tellis VA, Glicklich D, Soberman R, Veith FJ: Transplantation with past positive crossmatch and cyclosporine immunosuppression - A five year experience. Clin Transplantation 2: 336-340, 1988.
141. Fryd DS, Canafax DM, Matas AJ, Dunn D, Payne WD, Sutherland DER, Najarian JS: A comparison of two cyclosporine protocols at the University of Minnesota. In: Terasaki P (ed): Clinical Transplants 1988, Los Angeles: UCLA Tissue Typing Laboratory, 1988, pp 79-90.
142. Tellis V, Matas A, Soberman R, Principe A, Quinn T, Mallis M, Veith F: Long-term patient survival after cadaver renal transplantation. Transplant Proc 21: 2186, 1989.
143. Quinn T, Louis P, Mallis M, Senitzer DS, Tellis V, Matas A: A past positive crossmatch does not affect allograft survival for cyclosporine immunosuppressed primary and secondary renal transplant recipients. Transplant Proc 21: 704, 1989.
144. Matas A, Tellis V, Quinn T, Mallis M, Glicklich D, Senitzer DS, Soberman R: Long-term results of O-antigen match cadaver transplants - A single institution study. Transplant Proc 21: 682, 1989.
145. *Tellis VA, Matas AJ, Senitzer DS, Louis P, Glicklich D, Soberman R, Veith F: Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplantation 47: 127-129, 1989.
146. Reisfeld D, Matas AJ, Tellis VA, Quinn TA, Glicklich D, Soberman RJ, Bakal C, Sprayragen S, Veith FJ: Late follow-up of percutaneous transluminal angioplasty for treatment of transplant renal artery stenosis. Transplant Proc 21: 1955-1956, 1989.
147. *Gruber S, Chavers B, Payne W, Fryd D, Canafax D, Simmons R, Najarian J, Matas A: Allograft renal vascular thrombosis: Lack of increase with cyclosporine immunosuppression. Transplantation 47: 475-478, 1989.
148. Gruber SA, Burke BA, Canafax DM, Hrushesky WJM, Cipolle RJ, Erdmann GR, Matas A, Simmons RL, Najarian JS: Feasibility of vascular catheter placement for intrarenal infusion in a canine autotransplant model. Transplant Proc 21: 1125-1126, 1989.
149. Gruber SA, Chavers B, Payne WD, Fryd DS, Canafax DM, Simmons RL, Najarian JS, Matas A.: Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution. Transplant Proc 21: 2139-2140, 1989.
150. *Matas AJ, Tellis VA, Quinn T, Principe A, Mallis M, Glicklich D, Veith F: Short- and long-term graft survival with O antigen-matched first cadaver renal transplants - A single institution study. Clin Transplantation 3: 22-26, 1989.
151. *Matas A, Fryd D: Renal transplantation - The importance of well designed single institution and multicenter studies. Clin Transplantation 3: 63-65, 1989.
152. Louis P, Senitzer D, Tellis V, Matas A: Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplant Proc 21: 764-765, 1989.
153. Glicklich D, Tellis VA, Matas AJ, Mallis M, Quinn T, Soberman R, Veith FJ: No association between posttransplant erythrocytosis, thromboembolic events, and cyclosporine therapy. Transplant Proc 21: 2141-2142, 1989.
154. *Canafax DM, Min DI, Gruber SA, Fryd DS, Matas AJ, Payne WD, Dunn DL, Sutherland DER, Simmons RL, Najarian JS: Immunosuppression of cadaveric renal allograft recipients: A risk-factor matched comparison of the Minnesota randomized trial with an antilymphoblast globulin, azathioprine, cyclosporine, and prednisone protocol. Clin Transplantation 3: 110-119, 1989.
155. *Gruessner RWG, Matas AJ, Lloveras G, Fryd DS, Dunn DL, Payne WD, Sutherland DER, Najarian JS: A comparison of single and double pediatric cadaver donor kidneys for transplantation. Clin Transplantation 3: 209-214, 1989.
156. *Gruber SA, Venkataram S, Canafax DM, Cipolle RJ, Bowers L, Elsberry D, McGuiggan M, Hynes PE, Ritz JA, Gould FH, Matas A, Hrushesky WJM, Rahman YE: Liposomal formulation eliminates acute toxicity and pump incompatibility of parenteral cyclosporine. Pharm Res 6: 601-607, 1989.
157. Bumgardner GL, Ascher NL, Chen S, Cunningham TR, Payne WD, Matas AJ: Immunosuppressive factor in hepatocyte and liver cytosol. Surg Forum 40: 391-393, 1989.
158. Fasola C, Matas A, Payne W, Najarian J: Reversal of acute hepatic failure in a large animal model by autologous hepatocyte transplantation. Surg Forum 40: 347-349, 1989.
159. *Tzardis PJ, Gruessner RWG, Matas AJ, Fryd DS, Payne WD, Dunn DL, Sutherland DER, Najarian JS: Renal transplantation in patients with polycystic kidney disease: a single center experience. Clin Transplantation 3: 325-330, 1989.
160. *Gruessner RWG, Matas AJ, Lloveras G, Fryd DS, Dunn DL, Payne WD, Sutherland DER, Najarian JS: Pediatric donors - a risk factor in renal retransplantation. Clin Transplantation 3: 349-354, 1989.
161. *Gruber SA, Hrushesky WJM, Cipolle RJ, Erdmann GR, Burke BA, Skjei KL, Mueller RP, Fryd DS, Matas AJ, Simmons RL, Canafax DM: Local immunosuppression with reduced systemic toxicity in a canine renal allograft model. Transplantation 48: 936-943, 1989.
162. *Gruber SA, Hrushesky WJM, Canafax DM, Cipolle RJ, Burke BA, Matas AJ, Ascher NL, Simmons RL: Local prednisolone infusion of canine renal allografts. Transplantation 48: 1072-1075, 1989.
163. *Matas AJ, Sutherland DER, Payne WD, Dunn DL, Perry E, Najarian JS: New approaches to living donor renal transplantation. Minn Med 72: 589-592, 1989.
164. Chavers BM, Matas AJ, Nevins TE, Mauer SM, Sutherland DER, Payne W, Dunn D, Gillingham K, Najarian JS: Results of pediatric kidney transplantation at the University of Minnesota. In Clinical Transplants 1989, Terasaki P (ed) Los Angeles, CA: UCLA Tissue Typing Laboratory, 1989, pp 253-266.
165. *Gruber SA, Canafax DM, Cipolle RJ, Erdmann GR, Burke BA, Matas AJ, Simmons RL, Hrushesky WJM: Local immunosuppression of the vascularized graft. Surgery 107: 210-214, 1990.
166. *Gruber SA, Cipolle RJ, Tzardis P, Skjei KL, Jossart G, Abed JF, Canafax DM, Burke BA, Matas AJ, Hrushesky WJM: Pharmacodynamics of local heparin infusion in a canine renal allograft model. J Pharmacol Exp Ther 252: 733-738, 1990.
167. *Greenstein SM, Schechner RS, Louis P, Senitzer D, Matas AJ, Veith FJ, Tellis VA: Evidence that zero antigen-matched cyclosporine-treated renal transplant recipients have graft survival equal to that of matched recipients. Transplantation 49: 332-336, 1990.
168. *Bumgardner GL, Matas AJ, Chen S, Cahill D, Cunningham TR, Payne WD, Bach FH, Ascher NL.: Comparison of in vivo and in vitro immune response to purified hepatocytes. Transplantation 49: 429-436, 1990.
169. *Chan GLC, Erdmann GR, Gruber SA, Matas AJ, Canafax DM: Azathioprine metabolism: Pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients. J Clin Pharmacol 30: 358-363, 1990.
170. Wrenshall L, Matas AJ, Payne WD, Sutherland DER, Bolman RM, Cerra F: Critical care of the transplant patient. In: Berk JL and Sampliner JE (eds): Handbook of Critical Care, Boston: Little, Brown and Company, 1990, pp 729-752.
171. Schechner RS, Schlumpf R, Tellis VA, Greenstein SM, Matas AJ: Receipt of shared organs at two geographically separate centers-the impact of UNOS. Transplant Proc 22: 305, 1990.
172. Gruessner RWG, Matas AJ, Dunn DL, Lloveras, G, Payne WD, Sutherland DER, Najarian JS: A comparison of pediatric versus adult cadaver donor kidneys for transplantation. Transplant Proc 22: 361-362, 1990.
173. Dunn DL, Schlumpf RB, Gruessner RWG, Morel P, Mayoral JL, Payne WD, Matas AJ, Sutherland DER, Moudry-Munns KC, Najarian JS: Maximal use of liver and pancreas from cadaveric organ donors. Transplant Proc 22: 423-424, 1990.
174. Gruessner RWG, Dunn DL, Tzardis PJ, Tomadze G, Moudry-Munns KC, Matas AJ, Najarian JS, Sutherland DER: Simultaneous pancreas and kidney transplants versus single kidney transplants and previous kidney transplants in uremic patients and single pancreas transplants in nonuremic diabetic patients: comparison of rejection, morbidity, and long-term outcome. Transplant Proc 22: 622-623, 1990.
175. *Tzardis PJ, Gruessner RWG, Matas AJ, Payne WD, Dunn DL, Sutherland DER, Najarian JS: Long-term follow-up of renal transplantation for Wegener's disease. Clin Transplantation 4: 108-111, 1990.
176. *Tellis VA, Reisfeld D, Matas AJ, Sprayragen S, Bakal C, Soberman R, Glicklich D, Veith FJ: Long-term results of percutaneous transluminal angioplasty for treatment of renal artery stenosis. Dial and Transpl 19: 22-28, 1990.
177. *Fabrega A, Matas AJ, Payne WD, Fryd DS, Dunn DL, Sutherland DER, Najarian JS: Ten- to 20-year follow-up of 123 consecutive HLA-identical living-related kidney transplants from the pre-cyclosporine era. Clin Transplantation 4: 145-152, 1990.
178. *Gruessner RWG, Tzardis PJ, Matas AJ, Dunn DL, Payne WD, Sutherland DER, Najarian JS: Ileal and colon conduits in renal transplantation. Clin Transplantation 4: 125-128, 1990.
179. *Matas AJ, Brayman KL, Gillingham KJ: Presentation of renal transplant graft survival data - where should "death with a functioning graft" be included? Clin Transplantation 4: 142-144, 1990.
180. Fischel RJ, Bolman RM, Platt JL, Najarian JS, Bach FH, Matas AJ: Removal of IgM anti-endothelial antibodies results in prolonged cardiac xenograft survival. Transplant Proc 22: 1077-1078, 1990.
181. *Canafax DM, Seifeldin R, Gruber SA, Hadsall RS, Miles CJ, Najarian JS, Matas AJ, Cipolle RJ: The pharmacoeconomics of organ transplantation: increased drug costs with decreased hospitalization costs. Pharmacotherapy 10: 205-210, 1990.
182. *Wrenshall LE, Matas AJ, Canafax DM, Min DI, Sibley RJ, Dunn DL, Payne WD, Sutherland DER, Najarian JS: An increased incidence of late acute rejection episodes in recipients of cadaver renal allografts given azathioprine, cyclosporine and prednisone. Transplantation 50: 233-237, 1990.
183. Tzardis PJ, Gruessner RWG, Matas AJ, Fryd DS, Payne WD, Dunn DL, Sutherland DER, Najarian JS: Renal transplantation in patients with polycystic kidney disease: a single center experience. In Golematis (ed): Chrysophillis, Athens, Greece, May, 1990, pp 395-406.
184. Chavers BM, Matas AJ, Nevins TE, Mauer SM, Sutherland DER, Payne WD, Dunn DL, Gillingham K, Najarian JS: Present status of kidney transplantation in children at the University of Minnesota. In Golematis (ed): Chrysophillis, Athens, Greece, May, 1990, pp 601-612.
185. Najarian JS, Frey DJ, Matas AJ, Gillingham KJ, So SSK, Cook M, Chavers B, Mauer SM, Nevins TE: Renal transplantation in infants. Ann Surg 212: 353-357, 1990.
186. *Matas AJ, Frey DJ, Gillingham KJ, Noreen HJ, Reinsmoen NL, Payne WD, Dunn DL, Sutherland DER, Najarian JS: The impact of HLA matching on graft survival and on sensitization after a failed transplant - evidence that failure of poorly matched renal transplants does not result in increased sensitization. Transplantation 50: 599-607, 1990.
187. Fasola CG, Kim YS, Manivel JC, Cerra FB, Matas AJ, Payne WD: Reversal of acute hepatic failure in pigs by xenogeneic hepatocyte (HC) transplantation and by injection of supernatant from xenogeneic HC cultures. Surg Forum 51: 374-375, 1990.
188. Frey DJ, Matas AJ: Renal transplantation. In: Cerra F (ed): Critical Care Clinics, 6: 4: pp 899-910, 1990 (October).
189. *Tzardis PJ, Gruessner RWG, Matas AJ, Payne WD, Dunn DL, Sutherland, DER: Fate of native polycystic kidneys left in situ after renal transplantation. Clin Transplantation 4: 309-310, 1990.
190. *Canafax DM, Min DI, Matas AJ, Amend WJC, Ptachcinski RJ, Hakala TR, Grevel J, Houghton D, Kahan BD, Simmons RL, Najarian JS, Cipolle RJ: The effects of initial cyclosporine dose and timing on long-term creatinine levels in cadaver renal transplantation. Clin Transplantation 4: 321-328, 1990.
191. *Gruessner RWG, Schechner R, Heil J, Matas AJ, Sutherland DER: En-bloc simultaneous pancreas and kidney allotransplantation in the pig. J Surg Res 49: 366-370, 1990.
192. *Reinsmoen NL, Kaufman D, Matas AJ, Sutherland DER, Najarian JS, Bach FH: A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients. Transplantation 50: 783-790, 1990.
193. *Fischel R, Kim W, Cahill D, Bolman R, Matas A: Cellular immunity in species with variable rejection of vascularized grafts. J Surg Res 49: 302-305, 1990.
194. Fischel RJ, Kim W, Cahill D, Matas AJ: The cellular response to xenotransplantation. Curr Surg 47: 345-347, 1990.
195. *Bumgardner GL, Matas AJ, Payne WD, Dunn DL, Sutherland DER, Najarian JS: Renal transplantation in patients with paraproteinemias. Clin Transplantation 4: 399-405, 1990.
196. Almond PS, Bumgardner GL, Chen S, Cunningham T, Payne W, Matas AJ: Correlation of Class I antigen expression with immunogenicity. Current Surgery 47: 262-264, 1990.
197. *Platt JL, Vercellotti GM, Dalmasso AP, Matas AJ, Bolman RM, Najarian JS, Bach FH: Transplantation of discordant xenografts: a review of progress. Immunol Today 11: 450-456, 1990.
198. *So SKS, Gillingham K, Cook M, Mauer SM, Matas AJ, Nevins TE, Chavers BM, Najarian JS: The use of cadaver kidneys for transplantation in young children. Transplantation 50: 979-983, 1990.
199. Bumgardner GL, Chen S, Almond PS, Ascher NL, Payne WD, Matas AJ: Role of macrophages in the immune response to hepatocytes. J Surg Res 48: 568-572, 1990.
200. Sutherland DER, Gruessner RWG, Matas AJ, Lloveras G, Fryd DS, Dunn DL, Payne WD, Najarian JS: Transplantation of single and double kidneys from pediatric donors. In: Abouna GM, Kumar MSA and White AG (eds): Organ Transplantation 1990, Dordrecht: Kluwer Academic Publishers, 1990, 201-202.
201. *Dunn DL, Mayoral JL, Gillingham KJ, Loeffler CM, Brayman KL, Kramer MA, Erice A, Balfour HH, Fletcher CV, Bolman RM, Matas AJ, Payne WD, Sutherland DER, Najarian JS: Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 51: 98-106, 1991.
202. *Frey DJ, Matas AJ: Allocation of cadaver kidneys: a survey of the American Society of Transplant Surgeons. Clin Transplantation 5: 1-2, 1991.
203. Bumgardner GL, Almond PS, Chen SC, Matas AJ: Memory T cells generated in vitro to MHC class I+, II- hepatocytes. Transplant Proc 23: 104-105, 1991.
204. Chen S, Almond PS, Bumgardner GL, Bach FH, Matas AJ: The role of antigen presenting cells in secondary mixed lymphocyte hepatocyte cultures. Transplant Proc 23: 106-107, 1991.
205. Almond PS, Bumgardner GL, Chen S, Platt JL, Payne WD, Matas AJ: Immunogenicity of Class I+, Class II- hepatocytes. Transplant Proc 23: 108-109, 1991.
206. Reinsmoen NL, Matas AJ, Kaufman D, Sutherland DER, Najarian JS, Bach FH: Acquired donor-specific hyporesponsiveness in long-term kidney allograft recipients. Transplant Proc 23: 141-142, 1991.
207. Fischel RJ, Matas AJ, Platt JL, Perry E, Manivel C, Bach FH, Najarian JS, Bolman RM: Prolonged survival of a discordant cardiac xenograft in a rhesus monkey. Transplant Proc 23: 589-590, 1991.
208. Schlumpf R, Morel P, Loveras JJ, Condie RM, Matas AJ, Kurle J, Fasola CG, Najarian JS, Sutherland DER: Dextran 40 successfully replaces the non-essential hydroxyethylstarch in the UW solution for 72-hours simple cold storage of the canine kidney. Transplant Proc 23: 657-659, 1991.
209. Wrenshall LE, Platt JL, Chopek MW, Fischel R, Matas AJ: ABO-incompatible transplantation in pigtail macaque monkeys. Transplant Proc 23, 703-704, 1991.
210. Bumgardner GL, Almond PS, Chen SC, Matas AJ: Indirect antigen presentation of hepatocyte (HC) MHC class I antigen in HC-sponge matrix allografts. Transplant Proc 23: 835-836, 1991.
211. Morel P, Kaufman DB, Platt J, Brayman K, Field MJ, Lloveras JK, Almond PS, Fasola C, Kyriakides P, Tzardis P, Schlumpf R, Matas AJ, Sutherland DER: Islet xenotransplantation in a pre-clinical large animal model. Transplant Proc 23: 875-876, 1991.
212. Canafax DM, Graves NM, Hilligoss DM, Careleton BC, Gardner MJ, Matas AJ: Increased cyclosporine levels as a result of simultaneous fluconazole and cyclosporine therapy in renal transplant recipients: a double-blind, randomized pharmacokinetic and safety study. Transplant Proc 23: 1041-1042, 1991.
213. Frey DJ, Matas AJ, Gillingham KJ, Canafax DM, Payne WD, Dunn DL, Sutherland DER, Najarian JS: MALG vs OKT3 following renal transplantation - a randomized prospective trial. Transplant Proc 23: 1048-1049, 1991.
214. Gruber SA, Skjei KL, Sothern RB, Robison L, Tzardis P, Moss A, Gillingham K, Canafax DM, Matas AJ, Dunn DL: Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression. Transplant Proc 23: 1104-1105, 1991.
215. Almond PS, Troppmann C, Escobar F, Frey DJ, Matas AJ: Economic impact of delayed graft function. Transplant Proc 23: 1304, 1991.
216. Fasola CG, Kim YS, Morel P, Dunn DL, Sutherland DER, Payne WD, Matas AJ, Najarian JS: Kidney retransplantation: patients with a failed second kidney transplant should be considered for a third one. Transplant Proc 23: 1336, 1991.
217. Fischel RJ, Matas AJ, Payne WD, Gillingham KJ, Dunn DL, Sutherland DER, Najarian JS: Long-term outcome in 1-year graft survivors: comparison of diabetic and nondiabetic populations. Transplant Proc 23: 1337, 1991.
218. Troppmann C, Almond PS, Escobar FS, Morel, Ph, Papalois AE, Dunn DL, Payne WD, Sutherland DER, Matas AJ, Najarian JS: Donor age and cause of death affect cadaver renal allograft outcome. Transplant Proc 23: 1365-1366, 1991.
219. Gruber SA, Chavers B, Skjei KL, Sothern RB, Robinson L, Tzardis P, Moss A, Gillingham K, Canafax DM, Najarian JS, Matas AJ, Dunn DL: De novo cancer after pediatric kidney transplantation. Transplant Proc 23: 1373-1374, 1991.
220. Almond PS, Morel Ph, Matas AJ, Gillingham KJ, Chau KS, Brown A, Kashtan CE, Mauer SM, Chavers B, Nevins TE, Dunn DL, Sutherland DER, Payne WD, Najarian JS: Transplanted children with long-term graft function have an excellent quality of life. Transplant Proc 23: 1380-1381, 1991.
221. Najarian JS, Frey DJ, Matas AJ, So SKS, Cook M, Mauer SM, Chavers BM, Kashtan C, Gillingham KJ, Nevins TE: Successful kidney transplantation in infants. Transplant Proc 23: 1382-1383, 1991.
222. Almond PS, Morel Ph, Troppmann C, Matas AJ, Najarian JS, Chavers B: Progression of infantile cystinosis after renal transplantation. Transplant Proc 23: 1386, 1991.
223. *Fischel RJ, Payne WD, Gillingham KJ, Dunn DL, Sutherland DER, Matas AJ, Najarian JS: Long-term outlook for renal transplant recipients with one-year function: "Doctor, what are my chances?". Transplantation 51: 118-122, 1991.
224. *Mayoral JL, Loeffler CM, Fasola CG, Kramer MA, Orrom WJ, Matas AJ, Najarian JS, Dunn DL: Diagnosis and treatment of cytomegalovirus disease in transplant patients based upon gastrointestinal tract manifestations. Arch Surg 126: 2: 202-206, 1991.
225. *Schweitzer E, Matas AJ: A unique presentation of an anastomotic pseudoaneurysm. Vascular Surgery 25: 2: 131-135, 1991.
226. *Gruber SA, Chan GLC, Canafax DM, Matas AJ: Immunosuppression in renal transplantation; I. cyclosporine and azathioprine. Clin Transplantation 5: 65-85, 1991.
227. *Stephanian E, Gruber SA, Dunn DL, Matas AJ: Posttransplant lymphoproliferative disorders. Transplantation Reviews 5(2): 120-129, 1991.
228. *Canafax DM, Graves NM, Hilligoss DM, Carleton BC, Gardner MJ, Matas AJ: Interaction between cyclosporine and fluconazole in renal allograft recipients. Transplantation 51: 1014-1018, 1991.
229. *Gruber SA, Chan GLC, Canafax DM, Matas AJ: Immunosuppression in renal transplantation; II. cortisone, ALG and OKT3. Clin Transplantation 5: 219-232, 1991.
230. *Colon EA, Popkin MK, Matas AJ, Callies AL: Overview of noncompliance in renal transplantation. Transplantation Reviews 5: 3: 175-180, 1991.
231. *Morel Ph, Sutherland DER, Almond PS, Stoblen, F, Matas AJ, Najarian JS, Dunn DL: Assessment of renal function in type I diabetic patients after kidney, pancreas, or combined kidney-pancreas transplantation. Transplantation 51: 1184-1189, 1991.
232. *Morel Ph, Kaufmann, D, Matas AJ, Tzardis P, Field MJ, Lloveras JK, Sutherland DER: Total pancreatectomy in the pig for islet transplantation. Transplantation 52: 11-15, 1991.
233. *Morel Ph, Almond PS, Matas AJ, Gillingham KJ, Chau C, Brown A, Kashtan CE, Mauer SM, Chavers B, Nevins TE, Dunn DL, Sutherland DER, Payne WD, Najarian JS: Long-term quality of life after kidney transplantation in childhood. Transplantation 52: 47-53, 1991.
234. Perez R, Matas AJ, Gillingham KJ, Payne WP, Dunn DL, Gores PF, Sutherland DER, Najarian JS: Lessons learned and future hopes: three thousand renal transplants at the University of Minnesota. In: Terasaki, P. (ed): Clinical Transplants 1990, Los Angeles: UCLA Tissue Typing Laboratory, 1991, pp 217-231.
235. Matas AJ, Najarian JS: Therapeutic approaches to renal transplantation. In: Lichenstein, L.M. and Fauci, A.S. (eds): Current Therapy in Allergy Immunology and Rheumatology, B.C. Decker, Inc, 1991.
236. Boyle EM, Fischel RJ, Johnson EM, Leventhal J, Matas AJ, Bolman RM: Depletion of natural antibody following pretransplant cyclophosphamide allows prolonged xenograft survival. Current Surg 48: 463-465, 1991.
237. Najarian JS, Matas AJ: The present and future of kidney transplantation. Transplant Proc 23: 2075-2082, 1991.
238. *Gruber SA, Canafax DM, Cipolle RJ, Erdmann GR, Burke BA, Simmons RL, Hrushesky WJM, Matas AJ: Intraarterial infusion of immunosuppressants. Minerva Chir 46: 1: 75-79, 1991.
239. *Almond PS, Matas AJ, Gillingham KJ, Troppmann C, Payne WD, Dunn DL, Sutherland DER, Najarian JS: Risk factors for second renal allografts immunosuppressed with cyclosporine. Transplantation 52: 253-258, 1991.
240. *Modena FM, Hostetter TH, Salahudeen AK, Najarian JS, Matas AJ, Rosenberg ME: Progression of kidney disease in chronic renal transplant rejection. Transplantation 52: 239-244, 1991.
241. Matas AJ: Long-term kidney transplant outcome -- where do we go from here? Contemp Dialysis & Neph 12: 18-21, 1991.
242. *Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FJ: Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 52: 214-220, 1991.
243. *Morel Ph, Troppmann C, Almond PS, Schlumpf R, Gillingham KJ, Sutherland DER, Dunn DL, Payne WD, Matas AJ, Najarian JS: Multiorgan procurement does not affect the immediate outcome of kidney transplants. Clin Transplantation 5: 381-385, 1991.
244. *Almond PS, Matas AJ, Canafax DM: Fixed-rate reimbursement fails to cover costs for patients with delayed graft function. Pharmacotherapy 11: 5: 126S-129S, 1991.
245. Boyle EM, Fischel RJ, Johnson EM, Leventhal J, Matas AJ, Bolman RM: Depletion of natural antibody after pretransplant cyclophosphamide administration allows prolonged xenograft survival. Curr Surg 48: 463-465, 1991.
246. Schlumpf R, Morel Ph, Loveras JJ, Condie RM, Matas A, Kurle J, Najarian JS, Sutherland DER: Examination of the role of the colloids hydroxyethylstarch, dextran, human albumin, and plasma proteins in a modified UW solution. Transplant Proc 23: 2362-2365, 1991.
247. Brayman KL, Almond PS, Moss AA, Chen SC, Nakhleh R, Sutherland DER, Najarian JS, Matas AJ: Intermittent Rapamycin administration prevents autoimmune diabetes. Surg Forum 52: 405-407, 1991.
248. Almond PS, Chen S, Matas AJ: Cytotoxic T lymphocyte development requires IL-2 but not antigen processing. Surg Forum 52: 417-418, 1991.
249. *Schweitzer EJ, Matas AJ, Gillingham KJ, Payne WD, Gores PF, Dunn DL, Sutherland DER, Najarian JS: Causes of renal allograft loss: Progress in the '80s, Challenges for the '90s. Ann Surg 214: 6: 679-688, 1991.
250. *Almond PS, Matas AJ, Gillingham K, Moss, A, Mauer SM, Chavers B, Nevins T, Kashtan C, Dunn DL, Payne WD, Sutherland DER, Gores PF, Najarian JS: Pediatric renal transplants -- results with sequential immunosuppression. Transplantation 53: 46-51, 1992.
251. *Gruber SA, Erdmann GR, Burke BA, Moss A, Bowers L, Hrushesky WJM, Cipolle RJ, Canafax DM, Matas AJ: Mizoribine pharmacokinetics and pharmacodynamics in a canine renal allograft model of local immunosuppression. Transplantation 53: 12-19, 1992.
252. Boyle EM, Fischel RJ, Johnson EM, Leventhal J, Matas AJ, Bolman RM: Depletion of natural antibody after pretransplant cyclophosphamide administration allows prolonged xenograft survival. Curr Surg 48: 463-465, 1991.
253. Almond PS, Gillingham KJ, Sibley R, Moss A, Melin M, Leventhal J, Manivel C, Kyriakides P, Payne WD, Dunn DL, Sutherland DER, Gores PF, Najarian JS, Matas AJ. Renal transplant function after ten years of cyclosporine. Transplantation 53(2):316-323, 1992.
254. *Brayman KL, Stephanian E, Matas AJ, Schmidt W, Payne WD, Sutherland DER, Gores PF, Najarian JS, Dunn DL: Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg 127: 38-48, 1992.
255. *Stephanian E, Matas AJ, Gores P, Sutherland DER, Najarian JS Retransplantation as a risk factor for lymphocele formation. Transplantation 53: 676-678, 1992.
256. *Stephanian E, Matas AJ, Mauer SM, Chavers B, Nevins T, Kashtan C, Sutherland DER, Gores P, Najarian JS: Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis. Transplantation 53: 755-757, 1992.
257. *Bumgardner GL, Almond PS, Chen S, Ascher NL, Matas AJ: Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. I. The role of L3T4+ T cell in the development of allospecific cytotoxicity in hepatocyte-sponge matrix allografts. Transplantation 53: 857-862, 1992.
258. *Bumgardner GL, Almond PS, Chen S, Ascher NL, Matas AJ: Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. II. In vitro-generated "memory" cells to class I+ class II- hepatocytes. Transplantation 53: 863-868, 1992.
259. *Matas AJ, Payne WD, Gillingham KJ, Dunn DL, Sutherland DER, Najarian JS: Optimizing the immediate posttransplant prednisone dose -- A prospective randomized trial. Clin Transplantation 6: 73-76, 1992.
260. Moss AA, Almond PS, Chen SC, Fischel RJ, Salazar AJ, Matas AJ: Sublethal irradiation and syngeneic bone marrow transplant prolongs thyroid xenograft survival. Transplant Proc 24: 505, 1992.
261. Fischel RJ, King NJ, Boyle EM, Almond PS, Chen S, Bolman RM, Matas AJ: Evaluation of xenogeneic thyroid transplants as a model of cell-mediated response. Transplant Proc 24: 535-536, 1992.
262. Leventhal JR, Platt JL, Flores HC, Gruber SA, Matas AJ, Bolman RM: Inhibition of natural antibody synthesis by cyclophosphamide or 15-deoxyspergualin fails to prevent xenograft rejection in the guinea pig-to-rat model. Transplant Proc 24: 551, 1992.
263. Fischel RJ, Matas AJ, Perry E, Dalmasso A, Noreen H, Bolman RM: Plasma exchange, organ perfusion and immunosuppression reduce "natural" antibody levels as measured by binding to xenogeneic endothelial cells and prolong discordant xenograft survival. Transplant Proc 24: 574, 1992.
264. Boyle EM, Fischel RJ, Johnson EM, Leventhal J, Matas AJ, Bolman RM: Examination of the clonal deletion theory in the guinea pig to Lewis rat cardiac xenograft model. Transplant Proc 24: 632, 1992.
265. Brayman KL, Morel P, Field J, Lloveras JJ, Leventhal J, Nakhleh R, Jessurun J, Platt J, Matas AJ, Najarian JS, Gores PF, Sutherland DER: A comparison of mice and rats as recipients for canine islet xenografts. Transplant Proc 24: 651-652, 1992.
266. Leventhal J, Flores H, Gruber SA, Matas AJ, Bolman RM: Inhibition of natural antibody production by a combination of 15- deoxyspergualin, mizoribine, cyclophosphamide and splenectomy. Transplant Proc 24: 687, 1992.
267. Boyle EM, Fischel RJ, Johnson EM, Leventhal J, Matas AJ, Bolman RM: Pretransplant donor antigen and cyclophosphamide in the evaluation of the clonal deletion theory in the hamster to Lewis rat cardiac xenograft model. Transplant Proc 24: 698, 1992.
268. Johnson EM, Fischel RJ, Boyle EM, Matas AJ, Bolman RM: Plasma exchange, splenectomy, and cyclophosphamide for natural antibody removal: kinetics and xenograft survival. Transplant Proc 24: 701, 1992.
269. Flores HC, Leventhal JR, Gruber SA, Figueroa J, Platt JL, Manivel C, Bach FH, Matas AJ: Natural antibody production can be inhibited by 15-deoxyspergualin in a discordant xenograft model. Transplant Proc 24: 714, 1992.
270. Fischel RJ, King NJ, Manivel C, Almond PS, Chen S, Bolman RM, Matas AJ: The histopathologic appearance of rejected xenografts in the neovascularized and primarily vascularized rodent system. Transplant Proc 24: 631, 1992.
271. Flores H, Leventhal J, Gruber SA, Schaffer M, Bolman RM, Matas AJ: Mizoribine inhibits natural antibody production in a discordant xenograft model. Transplant Proc 24: 717, 1992.
272. Tzardis PJ, Gruber SA, Matas AJ, Golematis BCh, Najarian JS: Intrarenal infusion of immunosuppression through implantable pump in a canine auto and allotransplant model. Acta Chirurgica Hellenica 64: 1: 1992.
273. Tzardis PJ, Gruessner RWG, Matas AJ, Sutherland DER, Najarian JS: Renal transplantation for polycystic kidney disease. Long-term follow-up of the transplanted and the native kidneys. Acta Chirurgica Hellenica 64: 1: 1992.
274. Morel Ph, Moss A, Schlumpf R, Nakhleh R, Lloveras JK, Field MJ, Condie R, Matas AJ, Sutherland DER: 72-hour preservation of the canine pancreas: successful replacement of hydroxyethylstarch by dextran-40 in UW solution. Transplant Proc 24: 791-794, 1992.
275. Cheung AHS, Sutherland DER, Dunn DL, Moudry-Munns KC, McHugh L, Gillingham K, Najarian JS, Matas AJ: Morbidity following simultaneous pancreas-kidney transplants vs kidney transplants alone in diabetic patients. Transplant Proc 24: 866-868, 1992.
276. Morel Ph, Kaufman DB, Field MJ, Lloveras JK, Matas AJ, Sutherland DER: Detrimental effect of prednisone on canine islet autograft function. Transplant Proc 24: 1048-1050, 1992.
277. *Bumgardner GL, Matas AJ: Transplantation and pregnancy. Transplant Rev 6: 3: 139-162, 1992.
278. *Najarian JS, Almond PS, Mauer SM, Chavers B, Nevins T, Kashtan C, Matas AJ: Renal transplantation in the first year of life: The treatment of choice for infants with end-stage renal disease. J Am Soc Neph 2: 3: S228-S233, 1992.
279. *Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DER, Najarian JS: Sequential therapy - A prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation 54: 50-56, 1992.
280. *Leventhal J, Flores H, Gruber SA, Figueroa J, Platt JL, Manivel JC, Bach FH, Matas AJ, Bolman RM: Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation 54: 26-31, 1992.
281. Kaufman DB, Jones J, Matas AJ: New immunosuppressive agents: FK506, rapamycin, RS-61443, 15-deoxyspergualin. J Transplant Coordination 2: 20-27, 1992.
282. *Najarian JS, Chavers B, McHugh L, Matas AJ: 20 years or more of living donors. Lancet 340: 807-810, 1992.
283. *Fischel RJ, Matas AJ, Platt JL, Perry E, Noreen H, Shumway SJ, Bolman RM: Cardiac xenografting in the pig-to-rhesus monkey model: manipulation of antiendothelial antibody prolongs survival. J Heart Transplantation 2: 965-73, 1992.
284. *Dunn DL, Mayoral JL, Gillingham KJ, Sawyer MD, Kramer MA, Statz CL, McHugh L, Matas AJ, Gores PF, Payne WD, Sutherland DER, Najarian JS: Simultaneous treatment of concurrent rejection and tissue invasive cytomegalovirus disease without detrimental effects upon patient or allograft survival. Clin Transplantation 6: 413-420, 1992.
285. Almond PS, Gillingham K, Sibley R, Manivel C, Najarian JS, Matas AJ: The impact of cyclosporine and cyclosporine nephrotoxicity on long-term renal allograft function. Dialysis & Transplantation 21: 682-684, 1992.
286. *Basadonna G, Matas AJ, Najarian JS: Kidney transplantation in diabetic patients: The University of Minnesota experience. Kidney Int 42: S193-S196, 1992.
287. *Reinberg Y, Matas AJ, Manivel C, Gonzalez R, Gillingham K, Pryor JL: Outcome of renal transplantation or dialysis in patients with a history of renal cancer. Cancer 70:1564-1567, 1992.
288. *Cheung AHS, Sutherland DER, Gillingham KJ, McHugh LE, Moudry-Munns KC, Dunn DL, Najarian JS, Matas AJ: Simultaneous pancreas-kidney (SPK) transplant versus kidney transplants alone (KTA) in diabetic patients. Kidney Int 41: 924-929, 1992.
289. *Almond PS, Bumgardner GL, Chen S, Matas AJ. Pretransplant sensitization with major histocompatibility complex Class I+ and Class II- hepatocytes leads to accelerated skin graft rejection. J Surg Res 53: 182-187, 1992.
290. Basadonna G, Matas AJ, Gillingham K, Sutherland DER, Payne WD, Dunn DL, Gores PF, Gruessner RWG, Arrazola L, Najarian JS: Kidney transplantation in patients with type I diabetes: 25-year experience at the University of Minnesota. In: Terasaki, P. (ed): Clinical Transplants 1992, Los Angeles: UCLA Tissue Typing Laboratory, 1992, pp 227-237.
291. *Matas AJ: Hepatitis B positivity may not rule out kidney transplantation. J Critical Illness 8: 15-16, 1993.
292. *Almond PS, Matas AJ, Nakhleh R, Morel Ph, Troppmann C, Najarian JS, Chavers B: Renal transplantation for infantile cystinosis: long-term follow-up. J Ped Surg 28: 232-238, 1993.
293. *Schweitzer EJ, Canafax DM, Gillingham KJ, Najarian JS, Matas AJ: Phenytoin administration in renal allograft recipients on cyclosporine immunosuppression. Clin Transplantation 7: 9-13, 1993.
294. Flores HC, Cromwell JW, Leventhal JR, Najarian JS, Matas AJ: Does previous breast feeding affect maternal donor renal allograft outcome? A single institution experience. Transplant Proc 25: 212, 1993.
295. Farney AC, Noreen HJ, Sutherland DER, Reinsmoen N, Segall M, Gillingham K, Schmidt WJ, Matas AJ: Effect of reexposure to mismatched major histocompatibility complex on renal retransplant allograft survival. Transplant Proc 25: 213, 1993.
296. Leventhal JR, Dalmasso AP, Cromwell JW, Manivel CJ, Bolman RM III, Matas AJ: Complement depletion prolongs discordant cardiac xenograft survival in rodents and non-human primates. Transplant Proc 25: 398-399, 1993.
297. Moss A, Almond PS, Matas AJ, Gillingham K, Najarian JS: Predictors of improved outcome in second pediatric renal transplant recipients. Transplant Proc 25: 597, 1993.
298. Almond PS, Moss A, Nakhleh RE, Melin M, Chen S, Salazar A, Shirabe K, Matas AJ: Rapamycin in a porcine renal transplant model. Transplant Proc 25: 716, 1993.
299. Troppmann C, Almond PS, Payne WD, Dunn DL, Gores PF, Gruessner RWG, Sutherland DER, Matas AJ, Najarian JS: Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes. Transplant Proc. 25: 905, 1993.
300. Basadonna GP, Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Sutherland DER, Gores PF, Gruessner RWG, Najarian JS: Relationship between early vs late acute rejection and onset of chronic rejection in kidney transplantation. Transplant Proc 25: 910-911, 1993.
301. Almond PS, Matas AJ, Gillingham K, Dunn DL, Payne WD, Gores, P, Gruessner R, Najarian JS: Predictors of chronic rejection in renal transplant recipients. Transplant Proc 25: 936, 1993.
302. Jones JW, Hunter DR, Matas AJ: Successful percutaneous treatment of ureteral stenosis after renal transplantation. Transplant Proc 25: 1038, 1993.
303. Cheung AHS, Matas AJ, Gruessner RG, Dunn DL, Moudry-Munns KC, Najarian JS: Should uremic diabetic patients who want a pancreas transplant receive a simultaneous cadaver kidney-pancreas transplant or a living related donor kidney first followed by cadaver pancreas transplant? Transplant Proc 25: 1184, 1993.
304. Matas AJ, Gillingham KJ, Sutherland DER: How "death with function" should be considered when calculating renal transplant outcome. Transplant Proc 25: 1309, 1993.
305. Basadonna GP, Arrazola L, Matas AJ, Gruessner R, Schmidt W, Sutherland DER: Morbidity, mortality and long-term allograft function in kidney transplantation alone and simultaneous pancreas-kidney in diabetic patients. Transplant Proc 25: 1321, 1993.
306. Jones JW, Matas AJ, Gillingham KJ, Gores PF, Payne WD, Gruessner RWG, Sutherland DER, Najarian JS: Employment and disability after renal transplantation. Transplant Proc 25: 1368, 1993.
307. Kaufman DB, Matas AJ, Arrazola, L, Gillingham KJ, Sutherland DER, Payne WD, Dunn DL, Gores PF, Najarian JS: Transplantation of kidneys from zero haplotype-matched living donors and from distantly related and unrelated donors in the cyclosporine era. Transplant Proc 25: 1530, 1993.
308. Canafax DM, Carleton BC, Matas AJ, Payne WD, Dunn DL, Sutherland DER, Najarian JS: Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy. Transplant Proc 25: 1692, 1993.
309. *Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55: 752-757, 1993.
310. *Matas AJ, Gillingham KJ, Sutherland DER: Half-life and risk factors for kidney transplant outcome-importance of death with function. Transplantation 55: 757-760, 1993.
311. *Leventhal JR, Dalmasso AP, Cromwell JW, Platt JL, Manivel CJ, Bolman RM, Matas AJ: Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55: 857-865, 1993.
312. *Basadonna GP, Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Sutherland DER, Gores PF, Gruessner RWG, Najarian JS: Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 55: 993-995, 1993.
313. *Reinsmoen NL and Matas AJ: Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 55: 1017-1023, 1993.
314. *Jones JW, Hunter DW, Matas AJ: Percutaneous treatment of ureteral strictures after renal transplantation.
Transplantation 55: 1193-1194, 1993.
315. *Jones JW, Payne WD, Matas AJ: The living donor--risks, benefits, and related concerns. Transplant Reviews 7: 115-128, 1993.
316. *Leventhal JR, Matas AJ, Sun LH, Reif S, Bolman III RM, Dalmasso AP, Platt JL: The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 56: 1-8, 1993.
317. *Almond PS, Moss A, Nakhleh RE, Melin M, Chen S, Salazar A, Shirabe K, Matas AJ: Rapamycin: immunosuppression, hyporesponsiveness, and side effects in a porcine renal allograft model. Transplantation 56: 275-281, 1993.
318. *Najarian JS, Almond PS, Gillingham KJ, Mauer SM, Chavers BM, Nevins TE, Kashtan CE, Matas AJ: Renal transplantation in the first five years of life. Kidney Int 44: S-40-S-44, 1993.
319. *Matas AJ: Is MHC matching as a primary criterion in kidney allocation justified? Nature Genetics 5: 210-213, 1993.
320. *Jones JW, Gruessner RWG, Gores PF, Matas AJ: Hypoaldosteronemic hyporeninemic hyperkalemia after renal transplantation. Transplantation 56: 1013-1015, 1993.
321. Sutherland DER, Gores P, Farney A, Wahoff DC, Matas AJ, Dunn DL, Gruessner RWG, Najarian JS: Evolution of kidney, pancreas, and islet transplantation for diabetes at the University of Minnesota. Am J Surgery 166: 456-492, 1993.
322. *Gruessner RWG, Nakhleh R, Tzardis P, Platt JL, Schechner R, Gruessner A, Tomadze G, Matas A, Najarian JS, Sutherland DER: Rejection in single versus combined pancreas and kidney transplantation in pigs. Transplantation 56: 1053-1062, 1993.
323. Jones JW, Acton BE, Granger DK, Matas AJ: Pregnancy following kidney donation. Transplant Proc 25: 3082, 1993.
324. Jones JW, Halldorson J, Elick B, Granger DK, Matas AJ: Unrecognized health problems diagnosed during living donor evaluation: a potential benefit. Transplant Proc 25: 3083, 1993.
325. Reinsmoen NL, Hertz MI, Kubo S, Bolman RM, Matas AJ: Immune factors correlating with improved long-term graft outcome in kidney, lung, and heart transplants. Transplant Proc 25:3277-3278, 1993.
326. Matas AJ, Najarian JS: The role of HLA matching in kidney transplantation: 30 years after, In: Terasaki, P. (ed): Clinical Transplants, 1993. Los Angeles, CA, UCLA Tissue Typing Laboratory, p. 428-430, 1993.
327. Nevins TE and Matas AJ: Living-related kidney donation in (ed) Tejani AH and Fine RN, Pediatric Renal Transplantation, Wiley & Sons, Inc, New York, 1993.
328. Jones JW, Matas AJ, Najarian JS: Surgical Techniques in (ed) Tejani AH and Fine RN, Pediatric Renal Transplantation, Wiley & Sons, Inc, New York, 1993.
329. Gruber SA, Gillingham KJ, Sothern RB, Stephanian E, Chavers B, Matas AJ, Dunn DL. Cancer development in pediatric primary renal allograft recipients. Transplant Proc 26:3-4.
330. Fasola CG, Gillingham KJ, Troppmann C, Gruessner RWG, Gores PF, Dunn DL, Payne WD, Sutherland DER, Matas AJ, Najarian JS. Kidney transplant or retransplant can effectively treat congenital nephrotic syndrome: a single-center experience. Transplant Proc 26:9, 1994.
331. Troppmann C, Almond PS, Fasola CG, Benedetti E, Gruessner RWG, Dunn DL, Gores PF, Payne WD, Matas AJ, Najarian JS. Effect of Minnesota Antilymphocyte Globulin on T-lymphocytes and their subsets during induction therapy in pediatric renal transplantation. Transplant Proc 26:26-27, 1994.
332. Fasola CG, Gillingham KJ, Troppmann C, Gruessner RWG, Gores PF, Dunn DL, Payne WD, Sutherland DER,
Matas AJ, Najarian JS. Pediatric kidney retransplantation: 30 years of experience at a single institution. Transplant Proc 26:48, 1994.
333. Jones JW, Nevins T, McHugh L, Matas AJ, Najarian JS. Nutrition and growth in pediatric renal transplant recipients. Transplant Proc 26:62-63, 1994.
334. Granger DK, Burd RS, Schmidt WJ, Dunn DL, Matas AJ. Incidence and timing of infections in pediatric renal transplant recipients in the cyclosporine era. Transplant Proc 26:64, 1994.
335. Fryer JP, Benedetti E, Gillingham KJ, Najarian JS, Matas AJ. Steroid-related complications in pediatric kidney transplant recipients in the cyclosporine era. Transplant Proc 26:91-92, 1994.
336. Matas AJ. Trend towards long-term reduction in cyclosporin levels:a risk factor for chronic graft rejection? In: Salaman J (ed.) Long-Term Cyclosporine Therapy and Risk of Chronic Rejection: A Discussion. New York: Royal Society of Medicine Press, 1994: 11-18.
337. Jones JW, Gillingham KJ, Sutherland DER, Payne WD, Dunn DL, Gores PF, Gruessner RWG, Najarian JS, Matas AJ: Successful long-term outcome with 0-haplotype-matched living related kidney donors. Transplantation 57: 512-15, 1994.
338. *Gruessner RWG, Nakhleh R, Tzardis P, Schechner R, Gruessner AC, Matas AJ, Najarian JS, Sutherland DERS. Rejection patterms after simultaneous pancreasticoduodenal-kidney transplants in pigs. Transplantation 57: 756-60, 1994.
339. *Chavers BM, Eun-Mi K, Matas AJ, Gillingham KJ, Najarian JS. Causes of kidney allograft loss in a large pediatric population at a single center. Ped Neph 8: 57-61, 1994.
340. *Matas AJ, Burke JF, DeVault GA, Monaco A, Pirsch JD. Chronic rejection. J Am Soc Nephr 4: S23-30, 1994.
341. *Najarian JS, Gillingham KJ, Sutherland DER, Reinsmoen NL, Payne WD, Matas AJ. The impact of the quality of initial graft function on cadaver kidney transplants. Transplantation 57: 812-816, 1994.
342. *Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode0 on long-term renal allograft survival (t1/2). Transplantation 57: 857-859, 1994.
343. *Dunn DL, Gillingham KJ, Kramer MA, Schmidt WJ, Erice A, Balfour HH, Gores PF, Gruessner RWG, Matas AJ, Payne WD, Sutherland DER, Najarian JS. A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. Transplantation 57: 876-884, 1994.
344. *Leventhal JR, Sakiyalak P, Witson J, Simone P, Matas AJ, Bolman RM, Dalmasso AP. The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates. Transplantation 57: 974-978, 1994.
345. *Leventhal JR and Matas AJ: Xenotransplantation in rodents: A review and reclassification. Transplantation Rev 8: 80-92, 1994.
346. *Matas AJ, Gores PF, Kelley SL, Bielefield-Skrokov M, Kinaszczuk M, Gruessner RWG, Najarian JS. Pilot evaluation of 15-Deoxyspergualin for refractory acute renal transplant rejection. Clin Transplantation 8: 116-119, 1994.
347. *Matas AJ. Chronic rejection - Definition and correlates. Clin Transplant 8: 162-167, 1994.
348. *Fryer JP, Matas AJ. How to identify the best candidates for kidney transplantation. Protocols for making the best use of scarce donor organs. J Crit Illness 9: 362-375, 1994.
349. *Kim EM, Striegel J, Kim Y, Matas AJ, Najarian JS, Mauer SM. Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection. Kidney Int 45: 1440-1445, 1994.
350. Matas AJ. Trend towards long-term reduction in cyclosporin levels: a risk factor for chronic graft rejection? Clin Exp Pers Sandimmun Ther 4: 3-5, 1994.
351. Troppmann C, Gruessner RWG, Matas AJ, Dunn DL, Stevens RB, Najarian JS, Sutherland DER: Results with renal transplants performed after previous solitary pancreas transplants. Transplant Proc 26: 448-449, 1994.
352. *Matas AJ: Chronic rejection in renal transplant recipients - risk factors and correlates. Clin Transplantation 8: 332-336, 1994.
353. *Fryer JP, Granger DK, Leventhal JU, Gillingham KJ, Najarian JS, Matas AJ. Steroid related complications in the cyclosporine era. Clin Transplantation 8:224-229, 1994.
354. *Sharma AK, Myers TA, Hunninghake DB, Matas AJ, Kashtan CE. Hyperlipidemia in long-term survivors of pediatric renal transplantation. Clin Transplantation 8:252-257, 1994.
355. *Granger DK, Jenkins M, Moss AA, Chen S, Almond P, Matas AJ. Prolonged survival without posttransplant immunosuppression in a large animal model. Surgery 116 (2): 236, 1994.
356. *Gruber SA, Gillingham K, Sother RB, Stephanian E, Matas AJ, Dunn DL. De Novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients. Clin Transplantation 8:388-395, 1994.
357. *Benedetti E, Fryer J, Matas AJ, Sutherland DER, Payne WD, Dunn DL, Gores PF, Gruessner RWG, Najarian JS: Kidney transplant outcome with and without right renal vein extension. Clin Transplantation 8: 416-417, 1994.
358. *Gruber SA, Hewitt HM, Sorenson AL, Barber DL, Bowers L, Rynders G, Arrazola L, Matas AJ, Rosenberg ME, Canafax DM. Pharmacokinetics of FK506 after intravenous and oral administration in patients awaiting renal transplantation. J Clin Pharmacol 34;859-864, 1994.
359. *Scherrer L, Leventhal JR, Matas AJ, Dalmasso AP. Evidence that rat xenoreactive antibodies recognize multiple protein antigens on guinea pig endothelial cells and platelets. Transplantation 58:458-465, 1994.
360. *Fryer JP, Leventhal JR, Dalmasso AP, Chen S, Simone PA, Jessurun J, Sun LH, Reinsmoen NL, Matas AJ. Cellular rejection in discordant xenografts when hyperacute rejection is prevented: Analysis using adopted and passive transfer. Transplant Immun 1994; 2: 87-93.
361. *Gruber SA, Matas AJ. Etiology and pathogenesis of tumors occurring after organ transplantation. Transplantation Science 4:87-104, 1994.
362. *Matas AJ. "A cost-outcome analysis of retransplantation: The need for accountability" - A response. Transplantation Rev 8: 207-209, 1994.
363. *Benedetti E, Matas AJ, Hakim N, Fasola C, Gillingham K, McHugh L, Najarian JS. Renal transplantation for patients 60 years of age or older. Annals of Surgery 220:445-460, 1994.
364. Leventhal JR, Berry B, Simone P, Dalmasso AP, Bolman RM, Matas AJ. Study of the pathogenesis of delayed xenograft rejection in the guinea pig-to-rat model. Surgical Forum 65: 450-452, 1994.
365. Granger DK, Amin NB, Sorenson AL, Gillingham KJ, Canafax DM, Matas AJ. Cyclosporine levels impact early rejection episodes. Transplant Proc 26:2513-2515, 1994.
366. Reinsmoen NL, Hertz MI, Kubo SH, Bolman RM, Matas AJ. Reduced incidence of chronic rejection in cyclosporine-treated solid organ recipients with donor antigen-specific hyporeactivity. Transplant Proc 26: 2558-2559, 1994.
367. Benedetti E, Hakim NS, Matas AJ, Payne WD, Mauer SM, Nevins T, Kashten C, Chavers B, Najarian JS. Renal transplantation in cyclosporine immunosuppressed infants and children. Transplant Proc 26: 2766-2767, 1994.
368. Sorenson AL, Lovdahl M, Hewitt JM, Granger DK, Almond PS, Russlie HQ, Barber D, Matas AJ, Canafax DM. Effects of ketoconazole on cyclosporine metabolism in renal allograft recipients. Transplant Proc 26: 2822, 1994.
369. *Fryer JP, Benedetti E, Perry EH, Matas AJ. Antibody mediated rejection of an HLA identical, ABO incompatible kidney transplant after two failed cadaver transplants. Transplantation 58: 723-725, 1994.
370. *Reinsmoen NL, Bolman RM, Savik K, Butters K, Matas AJ, Hertz MI. Improved long-term graft outcome in lung transplantation recipients who develop donor antigen-specific hyporeactivity. J Heart Lung Transplant 13(1):30, 1994.
371. *Gruessner RWG, Dunn DL, Gruessner AC, Matas AJ, Najarian JS, Sutherland DER: Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants. Transplantation 57(11) 1598-1606, 1994.
372. Matas AJ: Chronic Allograft Rejection - Definition, and Clinical Laboratory Correlates, In: Lieberman R and Morris R. (eds): Principles of Immunosuppressive Drug Development. CRC Press. 1994.
373. *Hakim NS, Benedetti E, Pirenne J, Gillingham K, Payne WD, Dunn DL, Sutherland DER, Gruessner RW, Gores PF, Matas AJ, Najarian JS: Complications of ureterovesical anastomosis in kidney transplant patients: The Minnesota experience. Clin Transplantation 8:504-507, 1994.
374. *Fryer JP, Leventhal JR, Dalmasso AP, Chen SC, Simone PA, Goswitz JJ, Reinsmoen NL, Matas AJ. Beyond hyperacute rejection: Acclerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets. Transplantation 59: 171-176, 1994.
375. *Granger DK, Cromwell JW, Chen SC, Goswitz JJ, Morrow DT, Beierle FA, Sehgal SN, Canafax DM, Matas AJ. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy. Transplantation 59: 183-186,1994.
376. *Leventhal JR, Ranjit J, Fryer JP, Witson JC, Dalmasso AP, Derlich JM, Remiszewski J, Matas AJ, Bolman RM, III. Removal of baboon and human anti-porcine IgG and IgM natural antibodies by immunoadsorption: results of in vitro and in vivo studies. Transplantation 59: 294-300,1994.
377. *Wahoff DC, Matas AJ, Papalois BE, Everett JE, Nelson LA, Sutherland DER. Reactive oxygen scavenger dimethylthiourea does not improve canine renal graft survival after 72-hour cold storage. Research in Surgery, 6:51-53,1994.
378. Nevins TE, Matas AJ. Live related kidney donation. In: Tejani AH and Fine RN (eds.): Pediatric Renal Transplantation. Wiley-Liss, Inc., New York, 137-143, 1994.
379. Jones JW, Matas AJ, Najarian JS. Surgical Technique. In: Tejani AH and Fine RN (eds): Pediatric Renal Transplantation. Wiley-Liss, Inc., New York, 187-200, 1994.
380. *Troppmann C, Benedetti E, Gruessner RWG, Payne WD, Sutherland DER, Najarian JS, Matas AJ. Retransplantation after renal allograft loss due to noncompliance: Indications, outcome, and ethical concerns. Transplantation 59:467-471, 1994.
381. Troppmann C, Almond PS, Matas AJ, Najarian JS, Gruessner RWG. Die Nierentransplantation als Therapie der chronischen Niereninsuffizienz bei Kindern unter 1 Jahr - Ergebnisse von 30 Transplantationen zwishcen 1970 und 1992. (Kidney transplantation is the treatment of choice in children below one year of age with end stage renal disease - results of 30 transplants performed between 1970 and 1992.) Zentralbl. Kinderchir. 3: 10-21, 1994.
382. Troppmann C, Matas AJ, Najarian JS, Gruessner RWG. Ulcer conplications in the upper gastrointestinal tract after 1034 kidney transplantations: Localization, incidence and effects on the survival rates of transplants and patients. Lagenbecks Arch Chir suppl. 359-362, 1994..
383. *Chavers BM, Matas AJ, Gillingham KJ, Schmidt WJ, Najarian JS. Pediatric renal transplantation at the University of Minnesota: The cyclosporine years. Terasaki and Cecka, Eds. UCLA Tissue Typing Laboratory. Clin Transplant, pg 203, 1994.
384. *Matas AJ, Najarian JS. Kidney transplantation - The living donor. Terasaki and Cecka, Eds. UCLA Tissue Typing Laboratory. Clinical Transplants pg 372, 1994.
385. *Troppmann C, Gillingham K, Benedetti E, Almond PS, Gruessner RWG, Najarian JS, Matas AJ. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation - A multivariate analysis. Transplantation 59, 962-968, 1995.
386. *Fryer JP, Leventhal JR, Matas AJ. The emergence of xenotransplantation. Transplant Immunol, 3(1): 21-31, 1995.
387. *Benedetti E, Troppmann C, Gillingham KJ, Hakim NS, Gutowski K, Najarian JS, Sutherland DER, Payne WD, Dunn DL, Gores PF, Matas AJ, Gruessner RWG. Short- and long-term outcome of kidney transplants with multiple renal arteries. Ann Surg, 221 (4): 406-414, 1995.
388. Matas AJ, Dosificacion de Mantenimiento de sandimmun y Evolucion a Largo Plazo en el Trasplante Renal. Symposium Report. pg 47-53. Sevilla, Spain, 1995.
389. Najarian JS, Matas AJ. Organs should be shared on the basis of matching - CON. Transplant Proc 27 (1): 100-101, 1995
390. Reinsmoen NL, McSherry C, Jackson AJ, Hertz MI, Bolman RM, Matas AJ. Circulating donor antigen and response to donor antigen as predictors of long-term lung and kidney transplant success. Transplant Proc 27(1): 205-206, 1995
391. *Gruessner RWG, Fasola C, Benedetti E, Foshager MC, Gruessner AC, Matas AJ, Najarian JS, Goodale RL. Laparoscopic drainage of lymphoceles after kidney transplantation: Indications and limitations. Surgery 117: 288-95, 1995.
392. *Troppmann C, Papalois BE, Chiou A, Benedetti E, Dunn DL, Matas AJ, Najarian JS, Gruessner RWG. Incidence, complications, treatment, and outcome of ulcers of the upper gastrointestinal tract after renal transplantation during the cyclosporine era. J Am Coll Surg, 180: 433-443, 1995.
393. Reinsmoen NL, McSherry C, Jackson AJ, Hertz MI, Bolman RM, Matas AJ. Circulating donor antigen and response to donor antigen as predictors of long-term lung and kidney transplant success. Transplant Proc 27: 205-206, 1995.
394. Laskow DA, Vincenti F, Neylan J, Mendez R, Matas AJ. Phase II FK506 multicenter concentration control study: One-year follow-up. Transplant Proc 27: 809-811, 1995.
395. Cooperative Clinical Trials in Transplantation (CCTT) Research Group. Murine OKT4A mmunosuppression in cadaver donor renal allograft recipients: A cooperative pilot study (report 1). Transplant Proc 27: 863, 1995.
396. Troppmann C, Benedetti E, Gruessner RWG, Najarian JS, Matas AJ. Should patients with renal allograft loss due to noncompliance be retransplanted? Transplant Proc 27: 1093, 1995.
397. Laskow DA, Vincenti F, Neylan J, Mendez R, Matas AJ. Phase II FK506 multicenter concentration control study: One-year follow-up. Transplant Proc 27 (1): 809-811, 1995.
398. Troppmann C, Benedetti E, Gruessner RWG, Najarian JS, Matas AJ. Should patients with renal allograft loss due to noncompliance be retransplanted? Transplant Proc 27(1): 1093, 1995
399. *Pirenne J, Benedetti E, Kashtan CE, Giedo-Garcia E, Hakim N, Schroeder CH, Cook M, Sutherland DER, Matas AJ, Najarian JS. Kidney transplantation in the absence of the infrarenal vena cava. Transplantation, 59: 1739-1742, 1995.
400. *Agarwal A, Mauer SM, Matas AJ, Nath KA. Recurrent hemolytic uremic syndrome in an adult renal allograft recipient: Current concepts and management. JASN 6: 1160, 1995.
401. *Reinsmoen NL, McSherry C, Chavers B, Hertz MI, Matas AJ. Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients. Pediatric Nephrology, 9:S35-S39, 1995.
402. *Matas AJ, Almond PS, Moss A, Gillingham KJ, Sibley R, Payne WD, Dunn DL, Gruessner RWG, Sutherland DER, Manivel C, Najarian JS. Effect of cyclosporine on renal function in kidney transplant recipients -- Twelve-year follow-up. Clinical Transplantation, 9: 450-453, 1995.
403. *McSherry C, Hertz MI, Jackson AM, Butters K, Diko M, Matas AJ, Bolman RM, Reinsmoen NL. Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients. Clinical Transplantation 9: 442-449, 1995.
404. *Reinsmoen NL, Jackson A, McSherry C, Ninova D, Wiesner RH, Krom RAF, Hertz MI, Bolman RM, Matas AJ. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. Transplantation, 60: 1546-1554, 1995.
405. *Matas AJ, Knatterud ME. What, precisely, is "induction therapy"? A plea to standardize the term. Transplantation, 60: 1375-1377, 1995.
406. *Burke BA, Chavers BM, Gillingham KJ, Kashtan CE, Manivel JC, Mauer SM, Nevins TE, Matas AJ. Chronic renal allograft rejection in the first 6 months posttransplant. Transplantation, 60: 1413-1417, 1995.
407. *Kroshus TJ, Dalmasso AP, Leventhal JR, John R, Matas AJ, and Bolman RM. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection. J. Surg. Res. 59: 43-50, 1995.
408. *Hakim NS, Pirenne J, Benedetti E, Matas AJ. A technique of removal of the Tenckhoff peritoneal dialysis catheter. J Am Coll Surg, 180: 350-2, 1995.
409. Benedetti E, Hakim NS, Perez EM, Matas AJ. Renal transplantation. Acad Radiol 2(2):159-66, 1995.
410. *Matas AJ, Chavers BM, Nevins TE, Mauer SM, Kashtan CE, Cook M, Najarian JS. Recipient evaluation, preparation, and care in pediatric transplantation: The University of Minnesota protocols. Kidney International, 49: S99-S102, 1996.
411. *Agarwal A, Kim Y, Matas AJ, Alam J, Nath KA. Gas-generating systems in acute renal allograft rejection in the rat. Transplantation, 61: 93-98, 1996
412. *Farney AC, Matas AJ, Noreen HJ, Reinsmoen NL, Segall M, Schmidt WJ, Gillingham K, Najarian JS, Sutherland DER. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival? Clinical Transplantation, 10: 147-156, 1996.
413. Fryer J, Chen S, Simone P, Matas A. The role of macrophages in delayed vascular xenograft rejection. Am College of Surgeons - Surgical Forum 46: 396-397, 1995
414. Matas AJ. Chronic allograft rejection: definition and clinical laboratory correlates. In: R Lieberman and A Mukherjee, eds., Principles of Drug Development and Autoimmunity, Austin, Texas: R.G. Landes Co., 1996.
415. Johnson EM, Leventhal J, Dalmasso AP, Goswitz J, Simone P, Chen S, Moyle M, Matas AJ. Inactivation of C3 and C5 Prolongs Cardiac Xenograft Survival and Decreases Leukocyte Infiltration in a Model of Delayed Xenograft Rejection. Transplantation Proceedings. Vol. 28, no. 2 (April), 1996: p 603.
416. Johnson EM, Leventhal J, Dalmasso AP, Goswitz J, Simone P, Chen S, Moyle M, Matas AJ. Use of a Novel CD11b/CD18 Inhibitory Agent in a C6 Deficient Rat to Evaluate Delayed Xenograft Rejection. Transplantation Proceedings, Vol. 28, no. 2 (April), 1996: p 728.
417. *F. Vincenti, D.A. Laskow, J.F. Neylan, R. Mendez, A.J. Matas. One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. Transplantation, Vol. 61, no.11 (June), 1996: p 1576-1581.
418. *West M, Sutherland DERS, Matas AJ. Kidney transplant recipients who die with functioning grafts: serum creatinine level and cause of death. Transplantation 62(7):1029-1030, 1996.
419. *Laskow DA, Vincenti F, Neylan JF, Mendez R, Matas AJ. An open-label concentration-ranging trial of FK506 in primary kidney transplantation. Transplantation 62:900-905, 1996.
420. *Benedetti E, Pirenne J, Troppmann C, Hakim N, Moon C, Gruessner RWG, Sharp H, Matas AJ, Payne WD, Najarian JS. Combined liver and kidney transplantation. Transplant International 9:486-491, 1996.
421. Troppmann C, Papalois BE, Gruessner AC, Moon C, Matas AJ, Sehgal SN, Nakhleh RE, Gruessner RW. Perioperative immunosuppression as a critical determinant of early outcome after discordant xenoislet transplantation: a comparative study. Trans Proc 28(2):981-983, 1996.
422. Troppmann C, Papalois BE, Gruessner AC, Moon C, Matas AJ, Nakhleh RE, Gruessner RW. Impact of antipassenger lymphocyte globulin on functional graft survival of discordanta xenoislet grafts from a large animal donor. Trans Proc 28(2):842-844, 1996.
423. *Troppmann C, Gillingham KJ, Gruessner RW, Dunn DL, Payne WD, Najarian JS, Matas AJ. Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good graft function at 1 year after transplantation. Transplantation 61(9):1331-1337, 1996.
424. *Troppmann C, Gruessner AC, Papalois BE, Sutherland DE, Matas AJ, Benedetti E, Gruessner RW. Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome. Transplantation 61(9):1323-30, 1996.
425. Johnson EM, Zimmerman J, Duderstadt K, Chambers J, Sorenson AL, Granger DK, Almond PS, Fryer JP, Leventhal JR, Scarola J, Matas AJ, Canafax DM. A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients. Trans Proc 28(2):987, 1996.
426. Granger DK, Cromwell JW, Canafax DM, Matas AJ. Combined rapamycin and cyclosporine immunosuppression in a porcine renal transplant model. Trans Proc 28(2):984, 1996.
427. Johnson EM, Canafax DM, Gillingham K, Schmidt W, Pandian K, Najarian JS, Matas AJ. Do early cyclosporine levels affect the incidence of acute rejection in renal transplant recipients? Trans Proc 28(2):879, 1996.
428. Fryer JP, Chen S, Johnson EM, Simone P, Sun LH, Goswitz JJ, Matas AJ. Prolonged survival of discordant xenografts in a subset of complement-depleted rats. Trans Proc 28(2):700, 1996.
429. Fryer JP, Chen S, Johnson EM, Sun LH, Matas AJ. The different influences of allosensitization and xenosensitization on cellular rejection. Trans Proc 28(2):674, 1996.
430. Fryer JP, Chen S, Johnson EM, Simone P, Matas AJ. The role of macrophages in endothelial cell injury--a possible mechanism for delayed xenograft rejection. Trans Proc 28(2):626, 1996.
431. *Slovut DP, Benedetti E, Matas AJ. Babesiosis and hemophagocytic syndrome in an asplenic renal transplant recipient. Transplantation 62: 537-539, 1996.
432. Matas AJ. Elderly patients. In Medical roundtable on optimal immunosuppression in high-risk renal patients (Henry M, Ed). Medical Education Network, 1996, pp. 17-18.
433. *Matas AJ, Gillingham KJ, Chavers BM, Nevins T, Kashtan C, Mauer SM, Payne WD, Gruessner RWG, Najarian JS. The importance of early cyclosporine levels in pediatric kidney transplantation. Clin Trans 10: 482-486, 1996.
434. *Matas AJ. A third kidney transplant: Cost-effective treatment for end-stage renal disease? Clin Trans 10: 516-520, 1996.
435. *Wrenshall LE, McHugh L, Felton P, Dunn DL, Matas AJ. Pregnancy after donor nephrectomy. Transplantation 62: 1934-1936, 1996.
436. *Ingulli E, Matas AJ, Nevins TE, Kashtan CE, Mauer SM, Gillingham K, Chavers BM. Impact of age on renal allograft survival in children after the first rejection episode. Pediatric Nephrol 10: 474-478, 1996.
437. Garcia EL, Pirenne J, Hakim NS, Benedetti E, Kashtan CE, Cook M, Sutherland DE, Matas AJ, Najarian JS, Fernandez HC. Technical options of renal transplant in the absence of a viable ilio-caval venous circuit. Presentation of a case and review of the literature. Actas Urol Esp 20(6): 577-581, 1996.
438. Kerr S, Johnson E, Pandian K, Gillingham K, Matas AJ. Psychological impact of a failed kidney transplant.
Transplant Proc 29: 1573, 1997.
439. *CCTT Research Group (Cooperative Clinical Trials in Transplantation). Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a Cooperative Clinical Trials in Transplantation pilot study. Transplantation 63: 1087, 1997.
440. *Pirenne J, Lledo-Garcia E, Benedetti E, Hakim NS, Sutherland DER, Gruessner RWG, Najarian JS, Matas AJ. Colon perforation after renal transplantation: A single-institution review. Clin Transplantation 11: 88-93, 1997.
441. *Matas AJ, Lawson W, McHugh L, Gillingham K, Payne WD, Dunn DL, Gruessner RWG, Sutherland DER, Najarian JS. Employment patterns after successful kidney transplantation. Transplantation, 61: 729-33, 1996.
442. Matas AJ. Living donor transplantation. In: Hakim N, editor: Introduction to organ transplantation, Imperial College Press, London, 53-60, 1997.
443. West MS, Sutherland DER, Matas AJ. Considering death with function as a graft loss in kidney transplant recipients. Transplant Proc 29: 239, 1997.
444. *Chavers BM, Gillingham KJ, Matas AJ. Complications by age in primary pediatric renal transplant recipients. Pediatr Nephrol 11(4): 399-403, 1997.
445. *Matas AJ, Gillingham KJ, Elick BA, Dunn DL, Gruessner RW, Payne WD, Sutherland DE, Najarian JS. Risk factors for prolonged hospitalization after kidney transplants. Clin Transplant 11(4): 259-264, 1997.
446. *Birk PE, Matas AJ, Gillingham KJ, Mauer SM, Najarian JS, Chavers BM. Risk factors for chronic rejection in pediatric renal transplant recipients--a single center experience. Pediatr Nephrol 11(4): 395-398, 1997.
447. Humar AP, Leone JP, Matas AJ. Kidney transplantation: A brief review. Front Biosci 2: E41-E47, 1997.
448. Miller RB, Burke BA, Schmidt WJ, Gillingham KJ, Matas AJ, Mauer M, Kashtan CE. Recurrence of haemolytic uraemic syndrome in renal transplants: a single-centre report. Nephrol Dial Transplant 12(7): 1425-1430, 1997.
449. *Johnson EM, Remucal MJ, Gillingham KJ, Dahms RA, Najarian JS, Matas AJ. Complications and risks of living donor nephrectomy. Transplantation 64(8): 1124-1128, 1997.
450. *Nyberg SL, Manivel JC, Cook ME, Gillingham KJ, Matas AJ, Najarian JS. Grandparent donors in a living-related renal transplant program. Clin Transplantation 11(5) part 1: 349-353, 1997.
451. *Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ. Effect of early cyclosporine levels on kidney allograft rejection. Clin Transplantation 11(6): 552-557, 1997.
452. *Humar A, Johnson EM, Payne WD, Wrenshall L, Sutherland DER, Najarian JS, Gillingham KJ, Matas AJ. Effect of initial slow graft function on renal allograft rejection survival. Clin Transplatation 11(6): 623-627, 1997.
453. Stevens RB, Matas AJ. Renal retransplantation: the Minnesota experience. Transplant Immunol Letter 13 (4):4-10, 1997.
454. Matas AJ. Should pediatric kidneys be used for pediatric patients? Pediatr Transplantation 1(2): 102-103, 1997.
455. *Jackson A, McSherry C, Butters K, Diko M, Almond PS, Matas AJ, Reinsmoen NL. Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity. Hum Immunol 55:148-155, 1997.
456. Johnson, EM, Najarian JS, Matas AJ. Living kidney donation: donor risks and quality of life. In: Clinical Transplants 1997, Cecka and Terasaki, Eds. UCVA Press, 1997, pp. 231-240.
457. *Humar A, Johnson EM, Gillingham KJ, Sutherland DE, Payne WD, Dunn DL, Wrenshall LE, Najarian JS, Gruessner RW, Matas AJ. Venous thromboembolic complications after kidney and kidney-pancreas transplantation. Transplantation 65(2): 229-234, 1998.
458. *Humar A, Johnston EM, Payne WD, Dunn DL, Wrenshall LE, Najarian JS, Gruessner RWG, Matas AJ. The acutely ischemic extremity after kidney transplant: an approach to management. Surgery 123(3): 344-350, 1998.
459. *Jacobs C, Johnson E, Anderson K, Gillingham K, Matas AJ. Kidney transplants from living donors: how donation affects family dynamics. Adv Renal Replacement Therapy 5(2): 89-97, 1998.
460. *Matas AJ. Chronic allograft dysfunction: clinical definitions and risk factors. Graft 1(2)(Suppl.II): 48-51, 1998.
461. *Reinsmoen NL, Gillingham K, Jackson A, Butters K, McSherry C, Diko M, Hertz MI, Kubo S, Matas AJ. Can cellular assays predict chronic rejection? Graft 1(2)(Suppl. II): 60-65, 1998.
462. *Matas AJ, McHugh L, Payne WD, Wrenshall LE, Dunn DL, Gruessner RWG, Sutherland DER, Najarian JS. Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation. Clin Transplantation 12: 233-242, 1998.
463. *Matas AJ. Risk factors for chronic rejection-a clinical perspective. Transplant Immunology 6: 1-11, 1998.
464. Matas AJ, Najarian JS. Kidney Transplantation. In: O'Neill JA, Rowe MI, Grosfiell JL, Fonkalsrud EW, Coran AG, (eds), Pediatric Surgery. Mosby, St. Louis, 1998, pp. 563-581.
465. Sutherland DER, Gillingham KJ, Cecka M, Najarian JS, Payne WD, Gruessner RWG, Matas AJ. Living donors in kidney transplantation. In: Touraine JL, Traeger J, Betuel H, Dubernard JM, Revillard JP, Dupuy C, (eds), Retransplantation. Kluwer Academic Publishers, London, 1997, pp. 251-259.
466. *Humar A, Nevins TE, Remucal M, Cook ME, Matas AJ, Najarian JS. Kidney transplantation in children younger than 1 year using cyclosporine immunosuppression. Ann Surg 228(3): 421-428, 1998.
467. Matas AJ. Acute rejection is a major risk factor for chronic rejection. Transplant Proc 5:1766-8, 1998.
468. *Humar A, Grubbs B, Zapzalka D, Nazarian W, Hunter D, Matas AJ. Isolated iliac artery stenosis as a cause of kid.ney graft dysfunction posttransplant. Clin Transplantation 12(5):406-8, 1998.
469. *Matas AJ, Sutherland DER. Kidney transplantation without a final crossmatch. Transplantation 66(12):1835-1836, 1998.
470. *Hakim NS, Benedetti E, Payne WD, Gruessner R, Gores P, Sutherland DE, Najarian JS, Matas AJ. Pre-emptive renal transplantation. Int Surg 83(4):330-332, 1998.
471. *Vincenti F, Kirkman R, Light S, Bumgardner G. Pescovitz M, Halloran P, Neylan J, Wilkinson A, Ekberg H. Gaston R, Backman L, Burdick J for Daclizumab Triple Therapy Study Group. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N Engl J Med 338(3):161-5, 1998.
472. *Monaco AP, Burke JF, Ferguson RM, Halloran PF, Kahan BD, Light JA, Matas AJ, Solez K. Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion. Am J Kidney Dis 33(1):150-160, 1999.
473. *Humar A, Uknis M, Carlone-Jambor C, Gruessner RW, Dunn DL, Matas AJ. Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients. Transplantation 67(1): 94-97, 1999.
474. *Reinsmoen NR, Matas AJ, Donaldson L, Carter S, Cooperative Clinical Trial in Transplant Research Group. Impact of transfusions and acute rejection on posttransplant donor antigen-specific responses in two study populations. Transplantation 67(5):697-702, 1999.
475. *Johnson EM, Anderson JK, Jacobs C, Suh G, Humar A, Suhr BD, Kerr SR, Matas AJ. Long-term follow-up of living kidney donors: Quality of life after kidney donation. Transplantation 67(5):717-721, 1999.
476. *Kerr SR, Dalmasso AP, Apasova EV, Chen SS, Kirschfink M, Matas AJ. Mouse-to-rabbit xenotransplantation: a new small animal model of hyperacute rejection mediated by the classical complement pathway. Transplantation 67(3):360-5, 1999.
477. Troppmann C, Gruessner AC, Gillingham KJ, Sutherland DER, Matas AJ, Gruessner RWG. Impact of delayed function on long-term graft survival after solid organ transplantation. Transplant Proc 31:1290-1292, 1999.
478. Humar A, Kerr S, Hassoun A, Granger D, Suhr B, Matas A. The association between acute rejection and chronic rejection in kidney transplantation. Transplant Proc 31:1302-1303, 1999.
479. Matas AJ. The impact of acute rejection on chronic rejection: The adult experience. Graft (Supp II) 2(2):S44-S47, 1999.
480. *Matas AJ. Noncompliance and late graft loss: Implications for long-term clinical studies. Transplant Reviews 13(2): 78-82, 1999.
481. *Kerr SR, Matas AJ. Living donors >55 years: to use or not to use? Transplantation 67(7):999-1004, 1999.
482. *Kahan BD, Rajagopalan PR, Hall M for United States Simulect Renal Study Group. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2 receptor monocolonal antibody. Transplantation 67(2):276-84, 1999.
483. *Kandaswamy R, Kamps M, Matas AJ. Administration of OKT3 as a two-hour infusion does not attenuate first-dose side effects. Letter to the Editor, Transplantation 68(5):709-710, 1999.
484. *Matas AJ, Humar A, Payne WD, Gillingham KJ, Dunn DL, Sutherland DER, Najarian JS. Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection. Ann Surg 230(4):493-500, 1999.
485. *West M, Pirenne J, Chavers B, Gillingham K, Sutherland DER, Dunn DL, Matas AJ. Clostridium difficile colitis after kidney and kidney-pancreas transplantation. Clin Transplantation 13:318-323, 1999.
486. *Alexander JW, Light JA, Donaldson LA, Delmonico FL, Diethelm AG, Wilkinson A, Rosenthal JT, Thistlethwaite JR, Hunsicker LG, Matas AJ, First MR, Reinsmoen NL, Rose SM. Cooperative Clinical Trials in Transplant Research Group. Evaluation of pre- and post-transplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Transplantation 68(8):1117-1124, 1999.
487. *Humar A, Kerr S, Gillingham KJ, Matas AJ. Features of acute rejection that increase risk for chronic rejection. Transplantation 68(8):1200-1203, 1999.
488. *Humar A, Gillingham KJ, Kandaswamy R, Payne WD, Dunn DL, Sutherland DER, Matas AJ. Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation 68:1879-1883, 1999.
489. *Ahsan N, Hricik, Matas A, Rose S, Tomlanovich S, Wilkinson A, Ewell M